技术领域technical field
本发明属药物合成领域,具体涉及新的Penicillide衍生物、其制备方法及含有该衍生物的药物组合物以及其作为治疗剂的用途。The invention belongs to the field of medicine synthesis, and specifically relates to a new penicillide derivative, a preparation method thereof, a pharmaceutical composition containing the derivative and its use as a therapeutic agent.
背景技术Background technique
1974年由日本科研人员Sassa等人从菌类植物中提取出天然产物Penicillide,并确认了其基本结构(Tetrahedron Lett.1974,15(45),3941-3942.),而其绝对构型直到1992年才由Salituro等人确定(Bioorg.Med.Chem.Lett.1993,3(2),337-340.)。拜耳公司通过对Penicillide进行衍生化,并证实其衍生物具有很好的胆固醇酯转移蛋白抑制活性(拜耳公司的专利WO2004039453;Bioorg.Med.Chem.Lett.2005,15(15),3611-3614.)。有关天然产物Penicillide其衍生物的研发课题已引发本领域研究者的关注。In 1974, Japanese researchers Sassa and others extracted the natural product Penicillide from fungi, and confirmed its basic structure (Tetrahedron Lett.1974, 15(45), 3941-3942.), and its absolute configuration was not until 1992 The year was determined by Salituro et al. (Bioorg. Med. Chem. Lett. 1993, 3(2), 337-340.). Bayer Corporation derivatizes Penicillide, and confirms that its derivatives have good cholesteryl ester transfer protein inhibitory activity (Patent WO2004039453 of Bayer Corporation; Bioorg.Med.Chem.Lett.2005, 15 (15), 3611-3614. ). The research and development of the natural product Penicillide and its derivatives has attracted the attention of researchers in this field.
发明内容Contents of the invention
本发明的目的是提供新的Penicillide衍生物。The object of the present invention is to provide novel penicillide derivatives.
本发明的Penicillide衍生物为具有通式(I)的化合物:Penicillide derivatives of the present invention are compounds of general formula (I):
其中:in:
R1选自(1R,4S)-7-甲基二环[2.2.1]庚烷-7-羰基,4-溴苯甲酰基,4-三氟甲基苯甲酰基,3,5-二(三氟甲基)苯甲酰基;R1 is selected from (1R,4S)-7-methylbicyclo[2.2.1]heptane-7-carbonyl, 4-bromobenzoyl, 4-trifluoromethylbenzoyl, 3,5-di (Trifluoromethyl)benzoyl;
R2选自氢,甲基,对甲氧基苯基;R2 is selected from hydrogen, methyl, p-methoxyphenyl;
R3选自氢,甲氧基。R3 is selected from hydrogen, methoxy.
具体的,本发明所述的化合物,分别具有如下化学结构式:Specifically, the compounds described in the present invention respectively have the following chemical structural formulas:
本发明的进一步目的是提供上述Penicillide衍生物的药用用途。具体涉及述Penicillide衍生物在制备含有该衍生物的药物组合物以及其作为治疗剂的用途。A further object of the present invention is to provide the pharmaceutical use of the above-mentioned Penicillide derivatives. It specifically relates to the use of the Penicillide derivatives in the preparation of pharmaceutical compositions containing the derivatives and as therapeutic agents.
本发明所涉及的药物组合物,其含有治疗有效剂量的上述Penicillide衍生物和药学载体。The pharmaceutical composition involved in the present invention contains a therapeutically effective dose of the above-mentioned Penicillide derivatives and a pharmaceutical carrier.
本发明尤其涉及胆固醇酯转移蛋白抑制剂药物,其含有治疗有效剂量的上述Penicillide衍生物和药学载体。换言之,本发明提供了含有药物有效剂量的上述化合物的组合物,以及所述的化合物在制备胆固醇酯转移蛋白抑制剂药物中的用途。In particular, the present invention relates to a cholesteryl ester transfer protein inhibitor drug, which contains a therapeutically effective dose of the above-mentioned Penicillide derivative and a pharmaceutical carrier. In other words, the present invention provides a composition containing the above-mentioned compound in a pharmaceutically effective dose, and the use of the compound in the preparation of a cholesteryl ester transfer protein inhibitor drug.
本发明提供了如具体实施方式所述的上述Penicillide衍生物的合成方法。The present invention provides the synthesis method of the above-mentioned Penicillide derivatives as described in the specific embodiment.
具体实施方式Detailed ways
以下结合实施例用于进一步描述本发明,但这些实施例并非限制本发明的范围。The following examples are used to further describe the present invention, but these examples do not limit the scope of the present invention.
实施例1:制备下述化合物,Embodiment 1: prepare following compound,
1.步骤11. Step 1
250mL干燥的单口瓶中加入NaH(5.8g,144mmol),THF(72mL)溶解,滴加化合物2,3-二羟基苯甲醛(10.0g,72mmol)的THF(36mL)溶液,室温反应1小时。再缓慢加入溴化苄(12.3g,72mmol)的THF(18mL)溶液,室温反应24小时。再将反应液倒入水(300mL)中,二氯甲烷(3x100mL)萃取,水相用1N盐酸调pH值至2,再用二氯甲烷(3x100mL)萃取,1N盐酸(2x100mL)洗,合并有机相,无水MgSO4干燥,过滤,浓缩,柱层析PE∶EA=20∶1(Rf=0.42,PE∶EA=10∶1),后用乙醇重结晶得10.7g化合物1,收率65%。NaH (5.8g, 144mmol) was added to a 250mL dry one-necked bottle, THF (72mL) was dissolved, and a THF (36mL) solution of compound 2,3-dihydroxybenzaldehyde (10.0g, 72mmol) was added dropwise, and reacted at room temperature for 1 hour. A solution of benzyl bromide (12.3 g, 72 mmol) in THF (18 mL) was added slowly, and reacted at room temperature for 24 hours. Then the reaction solution was poured into water (300mL), extracted with dichloromethane (3x100mL), the aqueous phase was adjusted to pH 2 with 1N hydrochloric acid, extracted with dichloromethane (3x100mL), washed with 1N hydrochloric acid (2x100mL), and combined with organic phase, dried over anhydrous MgSO4 , filtered, concentrated, column chromatography PE: EA = 20: 1 (Rf = 0.42, PE: EA = 10: 1), and recrystallized with ethanol to obtain 10.7g of compound 1, the yield 65%.
1H-NMR(CDCl3,300MHz):δ11.12(s,1H,OH),9.92(s,1H,CHO),7.47-7.32(m,5H,Ar-H),7.20(dd,J=7.8,1.4Hz,1H,Ar-H),7.13(d,J=7.8Hz,1H,Ar-H),6.90(t,J=7.8Hz,1H,Ar-H),5.20(s,2H,CH2).MS(ESI):229.1(M+H)+.1 H-NMR (CDCl3 , 300MHz): δ11.12 (s, 1H, OH), 9.92 (s, 1H, CHO), 7.47-7.32 (m, 5H, Ar-H), 7.20 (dd, J= 7.8, 1.4Hz, 1H, Ar-H), 7.13(d, J=7.8Hz, 1H, Ar-H), 6.90(t, J=7.8Hz, 1H, Ar-H), 5.20(s, 2H, CH2 ). MS (ESI): 229.1 (M+H)+ .
2.步骤22. Step 2
250mL单口瓶中加入化合物1(5.02g,21.9mmol),加入甲醇(200mL),冰浴下分批加入NaBH4(3.34g,88.7mmol),再在室温下反应4h。减压浓缩,将得到的白色固体溶于3N盐酸,二氯甲烷(3x100mL)萃取,合并有机相,水(3x100mL)洗,无水Na2SO4干燥,过滤,浓缩得白色固体4.94g化合物2,收率98%。Compound 1 (5.02g, 21.9mmol) was added to a 250mL single-necked flask, methanol (200mL) was added, NaBH4 (3.34g, 88.7mmol) was added in batches under ice-cooling, and the reaction was continued at room temperature for 4h. Concentrate under reduced pressure, dissolve the resulting white solid in 3N hydrochloric acid, extract with dichloromethane (3x100mL), combine the organic phases, wash with water (3x100mL), dry over anhydrous Na2 SO4 , filter, and concentrate to give 4.94g of compound 2 as a white solid , yield 98%.
1H-NMR(CDCl3,300MHz):δ7.42-7.36(m,5H,Ar-H),6.91-6.79(m,3H,Ar-H),6.08(s,1H,OH),5.11(s,2H,CH2),4.74(s,2H,CH2),2.33(br s,1H,OH).MS(ESI):253.0(M+Na)+.1 H-NMR (CDCl3 , 300MHz): δ7.42-7.36 (m, 5H, Ar-H), 6.91-6.79 (m, 3H, Ar-H), 6.08 (s, 1H, OH), 5.11 ( s, 2H, CH2 ), 4.74 (s, 2H, CH2 ), 2.33 (br s, 1H, OH). MS (ESI): 253.0 (M+Na)+ .
3.步骤33. Step 3
100mL的单口瓶中加入化合物2(300mg,1.3mmol),再用干燥的二氯甲烷(5mL)溶解。加入对甲苯磺酸(24mg,0.13mmol),冰盐浴中搅拌15min后滴加3,4-二氢-2H-吡喃(0.12mL,1.37mmol),2h后停止反应。加入三乙胺(1mL)淬灭反应,有机相饱和食盐水(10mL)洗,无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=20∶1(Rf=0.60,PE∶EA=6∶1)得393mg化合物3,收率96%。Compound 2 (300 mg, 1.3 mmol) was added into a 100 mL single-necked bottle, and then dissolved with dry dichloromethane (5 mL). Add p-toluenesulfonic acid (24mg, 0.13mmol), stir in an ice-salt bath for 15min, then add 3,4-dihydro-2H-pyran (0.12mL, 1.37mmol) dropwise, and stop the reaction after 2h. Triethylamine (1 mL) was added to quench the reaction, the organic phase was washed with saturated brine (10 mL), dried over anhydrous Na2 SO4 , filtered, concentrated, column chromatography PE:EA=20:1 (Rf =0.60, PE :EA=6:1) to obtain 393mg of compound 3, yield 96%.
1H-NMR(CDCl3,400MHz):δ7.44-7.33(m,5H,Ar-H),6.94(dd,J=7.6,1.2Hz,1H,Ar-H),6.87(dd,J=7.8,1.2Hz,1H,Ar-H),6.80(t,J=7.8Hz,1H,Ar-H),6.38(s,1HOH),5.11(s,2H,CH2),4.86(d,J=12Hz,1H,CH2),4.76(t,J=3.8Hz,1H,CH),4.63(d,J=12Hz,1H,CH2),3.96-3.93(m,1H,CH2),3.58-3.55(m,1H,CH2),1.86-1.52(m,6H).MS(ESI):337.2(M+Na)+.1 H-NMR (CDCl3 , 400MHz): δ7.44-7.33 (m, 5H, Ar-H), 6.94 (dd, J=7.6, 1.2Hz, 1H, Ar-H), 6.87 (dd, J= 7.8, 1.2Hz, 1H, Ar-H), 6.80(t, J=7.8Hz, 1H, Ar-H), 6.38(s, 1HOH), 5.11(s, 2H,CH2 ), 4.86(d, J =12Hz, 1H, CH2 ), 4.76 (t, J=3.8Hz, 1H, CH), 4.63 (d, J=12Hz, 1H, CH2 ), 3.96-3.93 (m, 1H, CH2 ), 3.58 -3.55 (m, 1H, CH2 ), 1.86-1.52 (m, 6H). MS (ESI): 337.2 (M+Na)+ .
4.步骤44. Step 4
100mL的单口瓶中加入5-氨基-2-甲基苯酚(1.00g,8.13mmol),NaHCO3(2.05g,24.4mmol),H2O(33mL)和乙酸乙酯(28mL),室温搅拌至溶解后加入特戊酰氯(1.05mL,8.54mmol),1h后停止反应。有机相1N盐酸(1x30mL)洗,无水Na2SO4干燥,过滤,浓缩(Rf=0.75,PE∶EA=2∶1)得1.84g化合物4,收率97%。Add 5-amino-2-methylphenol (1.00g, 8.13mmol), NaHCO3 (2.05g, 24.4mmol), H2 O (33mL) and ethyl acetate (28mL) into a 100mL single-necked bottle, and stir at room temperature until After dissolution, pivaloyl chloride (1.05 mL, 8.54 mmol) was added, and the reaction was stopped after 1 h. The organic phase was washed with 1N hydrochloric acid (1×30 mL), dried over anhydrous Na2 SO4 , filtered, and concentrated (Rf =0.75, PE:EA=2:1) to obtain 1.84 g of compound 4 with a yield of 97%.
1H-NMR(CDCl3,400MHz):δ8.57(s,1H),7.89(s,1H),7.38(s,1H),6.99(d,J=7.8Hz,1H,Ar-H),6.39(d,J=7.8Hz,1H,Ar-H),2.19(s,3H,CH3),1.32(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ177.6,155.6,136.0,130.3,121.0,110.2,107.4,39.6,27.5(3C),15.6.MS(ESI):208.0(M+H)+.HRMS(APCI):Calcd.for C12H18NO2+(M+H)+:208.1338,found:208.1349.1 H-NMR (CDCl3 , 400MHz): δ8.57(s, 1H), 7.89(s, 1H), 7.38(s, 1H), 6.99(d, J=7.8Hz, 1H, Ar-H), 6.39 (d, J=7.8Hz, 1H, Ar-H), 2.19 (s, 3H, CH3 ), 1.32 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ177.6, 155.6, 136.0, 130.3, 121.0, 110.2, 107.4, 39.6, 27.5 (3C), 15.6. MS (ESI): 208.0 (M+H)+ .HRMS (APCI): Calcd. for C12 H18 NO2+ (M+H)+ : 208.1338, found: 208.1349.
5.步骤55. Step 5
50mL单口瓶中加入化合物4(1.00g,4.83mmol),K2CO3(1.67g,12.1mmol),氩气保护下加入DMF(10mL),再在室温下加入MeI(0.36mL,5.8mmol),4h后停止反应。加入H2O(10mL),乙酸乙酯萃取(3x20mL),水(2x50mL)洗,无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=6∶1(Rf=0.69,PE∶EA=4∶1)得1.00g化合物5,收率94%。Add compound 4 (1.00g, 4.83mmol), K2 CO3 (1.67g, 12.1mmol) to a 50mL single-necked bottle, add DMF (10mL) under argon protection, and then add MeI (0.36mL, 5.8mmol) at room temperature , Stop the reaction after 4h. Add H2 O (10 mL), extract with ethyl acetate (3x20 mL), wash with water (2x50 mL), dry over anhydrous Na2 SO4 , filter, concentrate, column chromatography PE:EA=6:1 (Rf =0.69, PE:EA=4:1) to obtain 1.00 g of compound 5 with a yield of 94%.
1H-NMR(CDCl3,300MHz):δ7.49(s,1H,Ar-H),7.32(br s,1H,NH),7.03(d,J=8.1Hz,1H,Ar-H),6.73-6.70(m,1H,Ar-H),3.84(s,3H,OCH3),2.17(s,3H,CH3),1.32(s,9H,t-Bu-H).MS(ESI):222.2(M+H)+.1 H-NMR (CDCl3 , 300MHz): δ7.49 (s, 1H, Ar-H), 7.32 (br s, 1H, NH), 7.03 (d, J=8.1Hz, 1H, Ar-H), 6.73-6.70(m, 1H, Ar-H), 3.84(s, 3H, OCH3 ), 2.17(s, 3H, CH3 ), 1.32(s, 9H, t-Bu-H).MS(ESI) : 222.2(M+H)+ .
6.步骤66. Step 6
50mL单口瓶中加入化合物5(500mg,2.26mmol),氩气保护下加入干燥的THF(10mL),冰盐浴下缓慢滴加n-buLi(4.5mL,7.24mmol,1.6M in THF)。滴加完毕后室温搅拌2h,然后通入CO2气体2h。随后加入H2O(30mL),乙酸乙酯萃取(1x20mL),水相用1N HCl调pH值至1,再用乙酸乙酯萃取(4x30mL),合并有机相,无水Na2SO4干燥,过滤,浓缩(Rf=0.24,PE∶EA=4∶1)得540mg化合物6,收率90%。Compound 5 (500mg, 2.26mmol) was added to a 50mL single-necked bottle, dry THF (10mL) was added under argon protection, and n-buLi (4.5mL, 7.24mmol, 1.6M in THF) was slowly added dropwise in an ice-salt bath. After the dropwise addition, stir at room temperature for 2 h, and then pass CO2 gas for 2 h. Then H2 O (30 mL) was added, extracted with ethyl acetate (1×20 mL), the aqueous phase was adjusted to pH 1 with 1N HCl, and then extracted with ethyl acetate (4×30 mL), the organic phases were combined and dried over anhydrous Na2 SO4 , Filtration and concentration (Rf =0.24, PE:EA=4:1) yielded 540 mg of compound 6 with a yield of 90%.
1H-NMR(CDCl3,300MHz):δ11.72(s,1H,COOH),8.63(d,J=8.7Hz,1H,Ar-H),7.40(d,J=8.4Hz,1H,Ar-H),3.92(s,3H,OCH3),2.32(s,3H,CH3),1.34(s,9H,t-Bu-H).MS(EI):265.1 H-NMR (CDCl3 , 300MHz): δ11.72(s, 1H, COOH), 8.63(d, J=8.7Hz, 1H, Ar-H), 7.40(d, J=8.4Hz, 1H, Ar -H), 3.92(s, 3H, OCH3 ), 2.32(s, 3H, CH3 ), 1.34(s, 9H, t-Bu-H). MS(EI): 265.
7.步骤77. Step 7
100mL的单口瓶中加入化合物6(12.6g,47.6mmol),甲醇溶解(50mL),后依次缓慢滴加浓硫酸(5.7mL),原甲酸三甲酯(5.7mL,52.4mmol),加热回流,3天后停止反应,冷却,DCM稀释(30mL),1N盐酸萃取有机相,水相用3N NaOH调pH值至13,后用DCM萃取(3x50mL),有机相无水Na2SO4干燥,过滤,浓缩(Rf=0.64,PE∶EA=3∶1)得7.41g化合物7,收率80%。Compound 6 (12.6g, 47.6mmol) was added to a 100mL single-necked bottle, dissolved in methanol (50mL), and then concentrated sulfuric acid (5.7mL) and trimethyl orthoformate (5.7mL, 52.4mmol) were slowly added dropwise successively, heated to reflux, Stop the reaction after 3 days, cool down, dilute with DCM (30mL), extract the organic phase with 1N hydrochloric acid, adjust the pH value of the aqueous phase to 13 with 3N NaOH, then extract with DCM (3x50mL), dry the organic phase with anhydrous Na2 SO4 , filter, Concentration (Rf =0.64, PE:EA=3:1) yielded 7.41 g of compound 7 with a yield of 80%.
1H-NMR(CDCl3,300MHz):δ7.03(d,J=8.4Hz,1H,Ar-H),6.40(d,J=8.7Hz,1H,Ar-H),5.01(br s,2H,NH2),3.93(s,3H,OCH3),3.74(s,3H,OCH3),2.16(s,3H,CH3).MS(ESI):196.1(M+H)+.1 H-NMR (CDCl3 , 300MHz): δ7.03 (d, J=8.4Hz, 1H, Ar-H), 6.40 (d, J=8.7Hz, 1H, Ar-H), 5.01 (br s, 2H, NH2 ), 3.93 (s, 3H, OCH3 ), 3.74 (s, 3H, OCH3 ), 2.16 (s, 3H, CH3 ). MS (ESI): 196.1 (M+H)+ .
8.步骤88. Step 8
250mL的单口瓶中加入化合物7(7.41g,38.0mmol),HBr(21mL),H2O(82mL),搅拌至溶解,冰盐浴下滴加NaNO2(2.86g,41.4mmol)的水溶液,搅拌1h。然后缓慢滴加CuBr(7.77g,54.3mmol)的氢溴酸(10mL)溶液,搅拌至没有气泡生成后,油浴80℃反应过夜。停止反应,冷却,DCM(3x100mL)萃取,合并有机相后,饱和NaHCO3(1x100mL)洗,无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=100∶1(Rf=0.62,PE∶EA=20∶1)得7.76g化合物8,收率79%。Compound 7 (7.41g, 38.0mmol), HBr (21mL), H2 O (82mL) were added to a 250mL single-necked bottle, stirred until dissolved, and an aqueous solution of NaNO2 (2.86g, 41.4mmol) was added dropwise in an ice-salt bath, Stir for 1h. Then a solution of CuBr (7.77 g, 54.3 mmol) in hydrobromic acid (10 mL) was slowly added dropwise, stirred until no bubbles were formed, and reacted overnight in an oil bath at 80°C. Stop the reaction, cool, extract with DCM (3x100mL), combine organic phases, wash with saturated NaHCO3 (1x100mL), dry with anhydrous Na2 SO4 , filter, concentrate, column chromatography PE:EA=100:1 (Rf = 0.62, PE:EA=20:1) to obtain 7.76g of compound 8, yield 79%.
1H-NMR(CDCl3,300MHz):δ7.23(d,J=8.4Hz,1H,Ar-H),7.09(d,J=8.1Hz,1H,Ar-H),3.96(s,3H,OCH3),3.79(s,3H,OCH3),2.26(s,3H,CH3).MS(ESI):259.0,261.1(M+H)+.1 H-NMR (CDCl3 , 300MHz): δ7.23(d, J=8.4Hz, 1H, Ar-H), 7.09(d, J=8.1Hz, 1H, Ar-H), 3.96(s, 3H , OCH3 ), 3.79 (s, 3H, OCH3 ), 2.26 (s, 3H, CH3 ). MS (ESI): 259.0, 261.1 (M+H)+ .
9.步骤99. Step 9
50mL的三口瓶中加入NBS(501mg,2.81mmol),偶氮二异丁腈(28mg,0.18mmol),氩气保护下加入化合物8(228mg,0.88mmol)的CCl4溶液(10mL),加热至回流,反应过夜后停止反应,冷却,过滤,浓缩,直接下一步。50ml含有粗品的反应瓶中缓慢滴加浓硫酸(5mL),室温搅拌,TLC监测至原料消失时停止反应,将反应液倒入冰水(10mL)中,乙酸乙酯(3x20mL)萃取,饱和NaHCO3(1x20mL)洗,水(1x30mL)洗,无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=40∶1(Rf=0.17,PE∶EA=50∶1)得208mg化合物9,收率87%。Add NBS (501mg, 2.81mmol) and azobisisobutyronitrile (28mg, 0.18mmol) into a 50mL three-necked flask, add compound 8 (228mg, 0.88mmol) under the protection of argon CCl4 solution (10mL), heat to Reflux, stop the reaction after reacting overnight, cool, filter, concentrate, and go directly to the next step. Slowly add concentrated sulfuric acid (5mL) dropwise to a 50ml reaction flask containing the crude product, stir at room temperature, and stop the reaction when the raw material disappears as monitored by TLC. Pour the reaction solution into ice water (10mL), extract with ethyl acetate (3x20mL), and saturate3 (1x20mL), washed with water (1x30mL), dried over anhydrous Na2 SO4 , filtered, concentrated, column chromatography PE:EA=40:1 (Rf =0.17, PE:EA=50:1) yielded 208mg Compound 9, yield 87%.
1H-NMR(CDCl3,300MHz):δ10.30(s,1H,CHO),7.78-7.74(m,1H,Ar-H),7.49-7.46(m 1H,Ar-H),3.99(s,3H,OCH3),3.98(s,3H,OCH3).MS(ESI):272.9,274.9(M+H)+.1 H-NMR (CDCl3 , 300MHz): δ10.30(s, 1H, CHO), 7.78-7.74(m, 1H, Ar-H), 7.49-7.46(m 1H, Ar-H), 3.99(s , 3H, OCH3 ), 3.98 (s, 3H, OCH3 ). MS (ESI): 272.9, 274.9 (M+H)+ .
10.步骤1010. Step 10
100mL单口瓶中加入化合物3(1.12g,3.55mmol),化合物9(0.808g,2.96mmol),Cu(0.474g,7.40mmol),CuO(0.592g,7.40mmol),DMAP(1.08g,8.88mmol),氩气保护下加入CH3CN(25mL),再加热至回流,反应17h后停止反应,冷却,DCM稀释(20mL),过滤,浓缩,柱层析PE∶EA=6∶1(Rf=0.11,PE∶EA=10∶1)得1.10g化合物10,收率73%。Add compound 3 (1.12g, 3.55mmol), compound 9 (0.808g, 2.96mmol), Cu (0.474g, 7.40mmol), CuO (0.592g, 7.40mmol), DMAP (1.08g, 8.88mmol) ), added CH3 CN (25mL) under argon protection, heated to reflux, stopped the reaction after 17h of reaction, cooled, diluted with DCM (20mL), filtered, concentrated, column chromatography PE:EA=6:1 (Rf =0.11, PE:EA=10:1) to obtain 1.10 g of compound 10 with a yield of 73%.
1H-NMR(CDCl3,400MHz):δ10.22(s,1H,CHO),7.71(d,J=4.7Hz,1H,Ar-H),7.27-7.13(m,7H,Ar-H),6.99(dd,J=8.1,1.4Hz,1H,Ar-H),6.43(d,J=8.8Hz,1H,Ar-H),5.02(s,2H,CH2),4.73(d,J=12Hz,1H,CH2),4.67-4.66(m,1H,CH),4.48(d,J=12Hz,1H,CH2),3.99(s,3H,OCH3),3.94(s,3H,OCH3),3.83-3.76(m,1H,CH2),3.51-3.45(m,1H,CH2),1.65-1.43(m,6H).MS(ESI):529.2(M+Na)+.1 H-NMR (CDCl3 , 400MHz): δ10.22 (s, 1H, CHO), 7.71 (d, J=4.7Hz, 1H, Ar-H), 7.27-7.13 (m, 7H, Ar-H) , 6.99(dd, J=8.1, 1.4Hz, 1H, Ar-H), 6.43(d, J=8.8Hz, 1H, Ar-H), 5.02(s, 2H, CH2 ), 4.73(d, J =12Hz, 1H, CH2 ), 4.67-4.66(m, 1H, CH), 4.48(d, J=12Hz, 1H, CH2 ), 3.99(s, 3H, OCH3 ), 3.94(s, 3H, OCH3 ), 3.83-3.76 (m, 1H, CH2 ), 3.51-3.45 (m, 1H, CH2 ), 1.65-1.43 (m, 6H). MS (ESI): 529.2 (M+Na)+ .
11.步骤1111. Step 11
100mL的单口瓶中加入化合物10(1.01g,2mmol),对甲苯磺酸(2mg),后加入异丙醇(9mL)和H2O(2mL),加热至回流过夜,停止反应,冷却,加入H2O(10mL),乙酸乙酯萃取(3x30mL),有机相水洗(1x30mL),无水MgSO4干燥,过滤,浓缩,柱层析PE∶EA=3∶1(Rf=0.14,PE∶EA=3∶1)得720mg化合物11,收率88%。Add compound 10 (1.01g, 2mmol) and p-toluenesulfonic acid (2mg) into a 100mL single-necked bottle, then add isopropanol (9mL) and H2 O (2mL), heat to reflux overnight, stop the reaction, cool, add H2 O (10 mL), extracted with ethyl acetate (3x30 mL), washed the organic phase with water (1x30 mL), dried over anhydrous MgSO4 , filtered, concentrated, column chromatography PE:EA=3:1 (Rf =0.14, PE: EA=3:1) to obtain 720mg of compound 11, the yield was 88%.
1H-NMR(CDCl3,400MHz):δ10.20(s,1H,CHO),7.73(d,J=8.6Hz,1H,Ar-H),7.26-7.14(m,6H,Ar-H),7.07(d,J=7.2Hz,1H,Ar-H),6.99(d,J=8.4Hz,1H,Ar-H),6.43(d,J=9.0Hz,1H,Ar-H),5.02(s,2H,CH2),4.60(s,2H,CH2),3.98(s,3H,OCH3),3.94(s,3H,OCH3),2.74(br s,1H,OH).13C-NMR(CDCl3,100MHz):δ187.7,165.5,161.9,160.7,150.5,140.2,136.3,135.3,131.6,128.3(2C),127.8,126.8(2C),126.7,123.4,121.3,117.5,114.0,110.0,70.5,64.7,60.5,52.9.MS(EI):422.HRMS(ESI):Calcd.for C24H22O7Na+(M+Na)+:445.1263,found:445.1262.1 H-NMR (CDCl3 , 400MHz): δ10.20 (s, 1H, CHO), 7.73 (d, J=8.6Hz, 1H, Ar-H), 7.26-7.14 (m, 6H, Ar-H) , 7.07(d, J=7.2Hz, 1H, Ar-H), 6.99(d, J=8.4Hz, 1H, Ar-H), 6.43(d, J=9.0Hz, 1H, Ar-H), 5.02 (s, 2H,CH2 ), 4.60 (s, 2H,CH2 ), 3.98 (s, 3H,OCH3 ), 3.94 (s, 3H,OCH3 ), 2.74 (brs, 1H, OH).13 C-NMR (CDCl3 , 100MHz): δ187.7, 165.5, 161.9, 160.7, 150.5, 140.2, 136.3, 135.3, 131.6, 128.3(2C), 127.8, 126.8(2C), 126.7, 123.4, 121.3, 117.5, 114.0, 110.0, 70.5, 64.7, 60.5, 52.9. MS (EI): 422. HRMS (ESI): Calcd. for C24 H22 O7 Na+ (M+Na)+ : 445.1263, found: 445.1262.
12.步骤1212. Step 12
100mL的单口瓶中加入化合物11(655mg,1.55mmol),用MeOH溶解(10mL),加入对甲苯磺酸(55mg,0.32mmol),室温搅拌1h后,加入NaOH(722mg,18.5mmol),加热至回流,反应过夜。停止反应,冷却,减压浓缩除去MeOH,用3N HCl调pH值至4,乙酸乙酯萃取(4x30mL),无水Na2SO4干燥,过滤,浓缩,得653mg化合物12粗品。Compound 11 (655mg, 1.55mmol) was added to a 100mL single-necked bottle, dissolved in MeOH (10mL), p-toluenesulfonic acid (55mg, 0.32mmol) was added, stirred at room temperature for 1h, NaOH (722mg, 18.5mmol) was added, and heated to Reflux and react overnight. The reaction was stopped, cooled, concentrated under reduced pressure to remove MeOH, adjusted to pH 4 with 3N HCl, extracted with ethyl acetate (4x30 mL), dried over anhydrous Na2 SO4 , filtered, and concentrated to obtain 653 mg of crude compound 12.
MS(ESI):407.0(M-H)-.MS(ESI): 407.0(MH)- .
13.步骤1313. Step 13
将化合物12的粗品(568mg,1.39mmol)和三乙胺(1.55mL,11.1mmol)溶于干燥的CH3CN(10mL)中,将上述制得的溶液室温下缓慢滴加到由碘化-2-氯-1-甲基吡啶(1.42g,5.57mmol)溶于干燥的CH3CN(40mL)所配置的溶液中。滴加完毕后,加热回流反应1h。后停止反应,冷却,减压浓缩除去CH3CN,加入H2O(20mL),DCM萃取(3x30mL),无水Na2SO4干燥,过滤,浓缩,柱层析DCM(Rf=0.67,PE∶EA=2∶1)得261mg化合物13,两步合计收率55%。The crude compound 12 (568mg, 1.39mmol) and triethylamine (1.55mL, 11.1mmol) were dissolved in dry CH3 CN (10mL), and the solution prepared above was slowly added dropwise at room temperature to the iodide- 2-Chloro-1-picoline (1.42 g, 5.57 mmol) was dissolved in dryCH3CN (40 mL). After the dropwise addition was completed, the reaction was heated to reflux for 1 h. After the reaction was stopped, cooled, concentrated under reduced pressure to remove CH3 CN, added H2 O (20 mL), extracted with DCM (3x30 mL), dried over anhydrous Na2 SO4 , filtered, concentrated, column chromatography DCM (Rf =0.67, PE:EA=2:1) to obtain 261 mg of compound 13, the total yield of the two steps was 55%.
1H-NMR(CDCl3,400MHz):δ10.35(s,1H,CHO),7.99(d,J=8.6Hz,1H,Ar-H),7.50-7.34(m,5H,Ar-H),7.08-7.01(m,3H,Ar-H),6.67(d,J=7.1Hz,1H,Ar-H),5.22(s,2H,CH2),5.18(s,2H,CH2),4.12(s,3H,OCH3).13C-NMR(CDCl3,100MHz):δ187.7,166.0,161.2,157.6,150.7,145.2,136.4,133.3,128.7(2C),128.1,127.8,127.2(2C),127.1,125.2,121.1,120.5,118.7,115.9,71.2,68.9,64.6.MS(ESI):391.2(M+H)+.HRMS(ESI):Calcd.for C23H18O6Na+(M+Na)+:413.1001,found:413.0987.1 H-NMR (CDCl3 , 400MHz): δ10.35 (s, 1H, CHO), 7.99 (d, J=8.6Hz, 1H, Ar-H), 7.50-7.34 (m, 5H, Ar-H) , 7.08-7.01 (m, 3H, Ar-H), 6.67 (d, J=7.1Hz, 1H, Ar-H), 5.22 (s, 2H, CH2 ), 5.18 (s, 2H, CH2 ),(__ 2C), 127.1, 125.2, 121.1, 120.5, 118.7, 115.9, 71.2, 68.9, 64.6. MS (ESI): 391.2 (M+H)+ .HRMS (ESI): Calcd.for C23 H18 O6 Na+ (M+Na)+ : 413.1001, found: 413.0987.
14.步骤1414. Step 14
新戊基溴化镁的制备:50mL两口瓶中加入Mg(1.045g,43.53mmol)和一粒碘,氩气保护下加入干燥的乙醚溶液(5mL),加入溴代新戊烷(5mL)的乙醚溶液(1mL),待反应引发后,加入剩余的溴代新戊烷的乙醚溶液(10mL),34℃反应12h。后定容后冷却备用。Preparation of neopentylmagnesium bromide: Add Mg (1.045g, 43.53mmol) and a grain of iodine to a 50mL two-necked bottle, add dry ether solution (5mL) under argon protection, add bromoneopentane (5mL) Diethyl ether solution (1 mL), after the reaction was initiated, the remaining diethyl ether solution (10 mL) of bromoneopentane was added, and reacted at 34°C for 12 h. After constant volume, cool for later use.
100mL单口瓶中加入化合物13(136mg,0.35mmol),氩气保护下,加入干燥的THF(10mL),冰浴下滴加新戊基溴化镁(0.53mL,1.40mmol),后自然升温至室温搅拌1h,加入饱和NH4Cl淬灭反应,乙酸乙酯萃取(3x30mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=5∶1(Rf=0.38,PE∶EA=3∶1)得146mg化合物14,收率90%。Compound 13 (136mg, 0.35mmol) was added to a 100mL single-necked bottle, under the protection of argon, dry THF (10mL) was added, and neopentylmagnesium bromide (0.53mL, 1.40mmol) was added dropwise in an ice bath, and then the temperature was naturally raised to Stir at room temperature for 1 h, add saturated NH4 Cl to quench the reaction, extract with ethyl acetate (3x30 mL), dry over anhydrous Na2 SO4 , filter, concentrate, column chromatography PE:EA=5:1 (Rf =0.38, PE :EA=3:1) to obtain 146mg of compound 14, the yield was 90%.
1H-NMR(CDCl3,400MHz):δ7.59(d,J=8.6Hz,1H,Ar-H),7.51-7.48(m,2H,Ar-H),7.42-7.33(m,3H,Ar-H),7.05-6.95(m,3H,Ar-H),6.65(d,J=7.3Hz,1H,Ar-H),5.22(s,2H,CH2),5.19-5.16(m,1H,CH),5.14(s,2H,CH2),3.98(s,3H,OCH3),1.87(d,J=4.8Hz,1H,OH),1.69-1.59(m,2H,CH2),1.03(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ167.3,154.1,152.0,150.6,146.3,137.6,136.7,131.0,128.6(2C),128.0,127.8,127.2(2C),124.5,121.3,119.4,118.0,116.0,71.4,69.0,66.5,62.7,52.2,30.7,30.1(3C).MS(ESI):463.1(M+H)+.HRMS(ESI):Calcd.forC28H29O6-(M-H)-:461.1964,found:461.1966.1 H-NMR (CDCl3 , 400MHz): δ7.59 (d, J=8.6Hz, 1H, Ar-H), 7.51-7.48 (m, 2H, Ar-H), 7.42-7.33 (m, 3H, Ar-H), 7.05-6.95(m, 3H, Ar-H), 6.65(d, J=7.3Hz, 1H, Ar-H), 5.22(s, 2H, CH2 ), 5.19-5.16(m, 1H, CH), 5.14 (s, 2H, CH2 ), 3.98 (s, 3H, OCH3 ), 1.87 (d, J=4.8Hz, 1H, OH), 1.69-1.59 (m, 2H, CH2 ) , 1.03(s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ167.3, 154.1, 152.0, 150.6, 146.3, 137.6, 136.7, 131.0, 128.6(2C), 128.0, 127.8, 127.2(2C), 124.5, 121.3, 119.4, 118.0, 116.0, 71.4, 69.0, 66.5, 62.7, 52.2, 30.7, 30.1(3C).MS(ESI): 463.1(M+H)+ .HRMS(ESI ): Calcd.for C28 H29 O6- (MH)- : 461.1964, found: 461.1966.
15.步骤1515. Step 15
50mL单口瓶中加入化合物14(296mg,0.64mmol),DMSO溶解(10mL)后,加入IBX(358mg,1.28mmol),室温搅拌过夜,停止反应,加入H2O(100mL),DCM萃取(4x40mL),水洗(1x50mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=4∶1(Rf=0.51,PE∶EA=3∶1)得283mg化合物15,收率96%。Add compound 14 (296mg, 0.64mmol) to a 50mL single-necked bottle, after DMSO dissolved (10mL), add IBX (358mg, 1.28mmol), stir at room temperature overnight, stop the reaction, add H2 O (100mL), DCM extraction (4x40mL) , washed with water (1x50mL), dried over anhydrous Na2 SO4 , filtered, concentrated, column chromatography PE:EA=4:1 (Rf =0.51, PE:EA=3:1) gave 283mg of compound 15, yield 96 %.
1H-NMR(CDCl3,400MHz):δ7.60(d,J=8.6Hz,1H,Ar-H),7.50-7.48(m,2H,Ar-H),7.43-7.34(m,3H,Ar-H),7.06-6.99(m,3H,Ar-H),6.67(d,J=7.2Hz,1H,Ar-H),5.22(s,2H,CH2),5.16(s,2H,CH2),3.96(s,3H,OCH3),2.91(s,2H,CH2),1.01(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ202.2,166.3,156.5,154.9,150.7,145.7,136.5,133.8,133.7,128.7(2C),128.1,127.8,127.2(2C),124.9,121.3,120.8,118.5,116.0,71.3,68.9,63.8,54.8,31.6(3C),29.8.MS(ESI):461.0(M+H)+.HRMS(ESI):Calcd.for C28H28O6Na+(M+Na)+:483.1784,found:483.1777.1 H-NMR (CDCl3 , 400MHz): δ7.60 (d, J=8.6Hz, 1H, Ar-H), 7.50-7.48 (m, 2H, Ar-H), 7.43-7.34 (m, 3H, Ar-H), 7.06-6.99 (m, 3H, Ar-H), 6.67 (d, J=7.2Hz, 1H, Ar-H), 5.22 (s, 2H, CH2 ), 5.16 (s, 2H, CH2 ), 3.96(s, 3H, OCH3 ), 2.91(s, 2H, CH2 ), 1.01(s, 9H, t-Bu-H).13 C-NMR(CDCl3 , 100MHz): δ202. 2, 166.3, 156.5, 154.9, 150.7, 145.7, 136.5, 133.8, 133.7, 128.7(2C), 128.1, 127.8, 127.2(2C), 124.9, 121.3, 120.8, 118.5, 116.0, 71.3, 68.9, 63.8 31.6 (3C), 29.8. MS (ESI): 461.0 (M+H)+ . HRMS (ESI): Calcd. forC28H28O6Na+ (M+Na)+ :483.1784 , found:483.1777 .
16.步骤1616. Step 16
50mL单口瓶中,氩气保护下加入(R)-Me-CBS(153μL,0.153mmol),减压除去其中的甲苯,再加入THF(7.7mL)。降温至-20℃,加入BH3·THF(0.66mL,0.66mmol,1M in THF),后缓慢滴加化合物15(237mg,0.51mmol)的THF溶液(7.7mL),3h滴加完毕。-20℃反应4h后停止反应,加入H2O(3mL)淬灭反应,乙酸乙酯萃取(3x15mL),有机相水洗(1x20mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=5∶1得225mg化合物16,收率95%,ee值86%。(手性柱拆分条件:PC-2柱,UV 214nm,正己烷∶异丙醇=50∶50,0.5mL/min)In a 50 mL single-necked flask, (R)-Me-CBS (153 μL, 0.153 mmol) was added under argon protection, toluene was removed under reduced pressure, and THF (7.7 mL) was added. Cool down to -20°C, add BH3 ·THF (0.66mL, 0.66mmol, 1M in THF), and then slowly add a THF solution (7.7mL) of compound 15 (237mg, 0.51mmol) dropwise for 3h. Stop the reaction after reacting at -20°C for 4h, add H2 O (3mL) to quench the reaction, extract with ethyl acetate (3x15mL), wash the organic phase with water (1x20mL), dry over anhydrous Na2 SO4 , filter, concentrate, and column chromatography PE:EA=5:1 yielded 225 mg of compound 16 with a yield of 95% and an ee value of 86%. (Chiral column resolution conditions: PC-2 column, UV 214nm, n-hexane:isopropanol=50:50, 0.5mL/min)
[α]D20=+36°(C=0.1,CHCl3).[α]D20 =+36° (C=0.1, CHCl3 ).
17.步骤1717. Step 17
50mL单口瓶中加入化合物16(42mg,0.09mmol),用EtOH(3mL)和EA(7mL)的混合溶液溶解后加入钯碳(4mg),通入H2,TLC监测至原料消失,过滤,浓缩,柱层析PE∶EA=3∶1(Rf=0.47,PE∶EA=2∶1)得29mg化合物17,收率85%。Add compound 16 (42mg, 0.09mmol) to a 50mL single-necked bottle, dissolve it with a mixed solution of EtOH (3mL) and EA (7mL), add palladium carbon (4mg), feed H2 , monitor by TLC until the raw material disappears, filter, and concentrate , column chromatography PE: EA = 3: 1 (Rf = 0.47, PE: EA = 2: 1) yielded 29 mg of compound 17 with a yield of 85%.
1H-NMR(CDCl3,400MHz):δ7.53(d,J=8.7Hz,1H,Ar-H),7.03(d,J=7.9Hz,1H,Ar-H),6.97-6.93(m,1H,Ar-H),6.83(d,J=8.7Hz,1H,Ar-H),6.82(s,1H,OH),6.54(d,J=7.5Hz,1H,Ar-H),5.15-5.12(m,3H),3.97(s,3H,OCH3),2.28(br s,1H,OH),1.64-1.51(m,2H,CH2),1.01(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ167.8,153.7,150.8,147.9,143.4,138.1,130.9,126.1,124.9,120.2,119.2,117.6,117.3,69.1,66.4,62.4,52.3,30.7,30.0(3C).MS(ESI):373.0(M+H)+.HRMS(ESI):Calcd.for C21H24O6Na+(M+Na)+:395.1471,found:395.1462,[α]D20=+23°(C=0.1,CHCl3).1 H-NMR (CDCl3 , 400MHz): δ7.53(d, J=8.7Hz, 1H, Ar-H), 7.03(d, J=7.9Hz, 1H, Ar-H), 6.97-6.93(m , 1H, Ar-H), 6.83(d, J=8.7Hz, 1H, Ar-H), 6.82(s, 1H, OH), 6.54(d, J=7.5Hz, 1H, Ar-H), 5.15 -5.12(m, 3H), 3.97(s, 3H, OCH3 ), 2.28(br s, 1H, OH), 1.64-1.51(m, 2H, CH2 ), 1.01(s, 9H, t-Bu- H).13 C-NMR (CDCl3 , 100MHz): δ167.8, 153.7, 150.8, 147.9, 143.4, 138.1, 130.9, 126.1, 124.9, 120.2, 119.2, 117.6, 117.3, 69.1, 66.4, 62.4, 52.3,[_____ α]D20 =+23° (C=0.1, CHCl3 ).
18.步骤1818. Step 18
25mL单口瓶中加入化合物a(500mg,3.24mmol)和干燥的二氯甲烷(4mL),0℃下后加入1滴DMF,再滴加草酰氯(0.34mL,3.9mmol),气体不再产生后,在室温下继续搅拌30分钟,再减压浓缩得酰氯b,用干燥的THF定容,直接参与下步反应。Add compound a (500mg, 3.24mmol) and dry dichloromethane (4mL) into a 25mL single-necked bottle, then add 1 drop of DMF at 0°C, then add oxalyl chloride (0.34mL, 3.9mmol) dropwise, after the gas is no longer generated , continue to stir at room temperature for 30 minutes, then concentrate under reduced pressure to obtain the acid chloride b, dilute to volume with dry THF, and directly participate in the next reaction.
25mL单口瓶中加入化合物17(29mg,0.078mmol)和干燥的THF(2mL),后加入NaH(3.4mg,0.086mmol),室温搅拌1h,后缓慢滴加酰氯b(17mg,0.10mmol)的THF(2mL)溶液,过夜后停止反应,直接板层析PE∶EA=3∶1(Rf=0.42,PE∶EA=3∶1)得23mg化合物18,收率58%。Add compound 17 (29mg, 0.078mmol) and dry THF (2mL) into a 25mL single-necked bottle, then add NaH (3.4mg, 0.086mmol), stir at room temperature for 1h, then slowly add acid chloride b (17mg, 0.10mmol) in THF (2 mL) solution, stopped the reaction after overnight, direct plate chromatography PE:EA=3:1 (Rf =0.42, PE:EA=3:1) gave 23 mg of compound 18, yield 58%.
1H-NMR(CDCl3,400MHz):δ7.61(d,J=8.2Hz,1H,Ar-H),7.09-7.07(m,2H,Ar-H),7.00(d,J=8.6Hz,1H,Ar-H),6.96-6.92(m,1H,Ar-H),5.18-5.11(m,3H),3.98(s,3H,OCH3),2.33(s,2H),1.97-1.84(m,5H),1.70-1.55(m,2H,CH2),1.45(s,3H,CH3),1.34-1.32(m,4H),1.03(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ175.3,167.1,153.9,151.2,148.4,142.3,138.3,131.1,127.6,127.2,124.5,124.2,119.6,118.3,69.1,66.4,63.0,58.6,52.3,42.0,30.7,30.1,29.4,27.8,17.1.HRMS(APCI):Calcd.for C30H35O7-(M-H)-:507.2383,found:507.2375,[α]D20=+10.8°(C=1.0,CHCl3).1 H-NMR (CDCl3 , 400MHz): δ7.61 (d, J=8.2Hz, 1H, Ar-H), 7.09-7.07 (m, 2H, Ar-H), 7.00 (d, J=8.6Hz , 1H, Ar-H), 6.96-6.92(m, 1H, Ar-H), 5.18-5.11(m, 3H), 3.98(s, 3H, OCH3 ), 2.33(s, 2H), 1.97-1.84 (m, 5H), 1.70-1.55 (m, 2H, CH2 ), 1.45 (s, 3H, CH3 ), 1.34-1.32 (m, 4H), 1.03 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ175.3, 167.1, 153.9, 151.2, 148.4, 142.3, 138.3, 131.1, 127.6, 127.2, 124.5, 124.2, 119.6, 118.3, 69.1, 66.4, 63.0, 53.6, 52.______ = 1.0, CHCl3 ).
实施例2:制备下述化合物,Embodiment 2: prepare following compound,
1.步骤11. Step 1
250mL单口瓶中加入实施例1步骤1所得化合物1(4.00g,17.5mmol),加入乙腈(90mL)溶解后,再依次加入醋酸铵(137mg,1.75mmol),NBS(3.28g,18.4mmol),室温下反应4h。减压浓缩除去乙腈,加水(100mL)稀释,乙酸乙酯(100mL)萃取,有机相无水MgSO4干燥,过滤,浓缩,柱层析PE∶EA=20∶1(Rf=0.35,PE∶DCM=2∶1),得4.59g化合物19,收率85%。Compound 1 (4.00g, 17.5mmol) obtained in step 1 of Example 1 was added to a 250mL one-mouth bottle, and after adding acetonitrile (90mL) to dissolve, ammonium acetate (137mg, 1.75mmol) and NBS (3.28g, 18.4mmol) were added in sequence, Reaction at room temperature for 4h. Concentrate under reduced pressure to remove acetonitrile, dilute with water (100 mL), extract with ethyl acetate (100 mL), dry the organic phase over anhydrous MgSO4 , filter, concentrate, column chromatography PE:EA=20:1 (Rf =0.35, PE: DCM=2:1), to obtain 4.59 g of compound 19, with a yield of 85%.
1H-NMR(CDCl3,400MHz):δ10.96(s,1H,OH),9.86(s,1H,CHO),7.46-7.35(m,5H,Ar-H),7.33(d,J=2.4Hz,1H,Ar-H),7.23(d,J=2.0Hz,1H,Ar-H),5.16(s,2H,CH2).MS(ESI):329.0,331.1(M+Na)+.1 H-NMR (CDCl3 , 400MHz): δ10.96(s, 1H, OH), 9.86(s, 1H, CHO), 7.46-7.35(m, 5H, Ar-H), 7.33(d, J= 2.4Hz, 1H, Ar-H), 7.23(d, J=2.0Hz, 1H, Ar-H), 5.16(s, 2H,CH2 ). MS(ESI): 329.0, 331.1(M+Na)+ .
2.步骤22. Step 2
50mL单口瓶中加入化合物19(307mg,1mmol),加入DMF(1mL)溶解后,再加入N,N-二异丙基乙胺(258mg,2mmol),10min后加入叔丁基二甲基氯硅烷(301mg,2mmol),室温下反应1h。加水(50mL)淬灭反应,乙酸乙酯(3x50mL)萃取,合并有机相后,水洗,饱和食盐水洗,无水MgSO4干燥,过滤,浓缩,柱层析PE∶EA=100∶1(Rf=0.78,PE∶EA=15∶1),得401mg化合物20,收率95%。Add compound 19 (307mg, 1mmol) to a 50mL single-necked bottle, add DMF (1mL) to dissolve, then add N,N-diisopropylethylamine (258mg, 2mmol), and add tert-butyldimethylsilyl chloride after 10min (301mg, 2mmol), react at room temperature for 1h. Add water (50mL) to quench the reaction, extract with ethyl acetate (3x50mL), combine the organic phases, wash with water, wash with saturated brine, dry over anhydrous MgSO4 , filter, concentrate, column chromatography PE:EA=100:1(Rf =0.78, PE:EA=15:1), to obtain 401mg of compound 20, yield 95%.
1H-NMR(CDCl3,400MHz):δ10.40(s,1H,CHO),7.52(d,J=2.4Hz,1H,Ar-H),7.42-7.41(m,5H,Ar-H),7.21(d,J=2.4Hz,1H,Ar-H),5.03(s,2H,CH2),0.92(s,9H,t-Bu-H),0.07(s,6H,CH3).13C-NMR(CDCl3,100MHz):δ188.7,151.3,148.5,135.0,128.9,128.7(2C),128.4(2C),121.9,121.1,113.7,71.4,25.7(3C),18.7,-4.3(2C).MS(ESI):421.1,423.1(M+H)+.1 H-NMR (CDCl3 , 400MHz): δ10.40 (s, 1H, CHO), 7.52 (d, J=2.4Hz, 1H, Ar-H), 7.42-7.41 (m, 5H, Ar-H) , 7.21 (d, J=2.4Hz, 1H, Ar-H), 5.03 (s, 2H, CH2 ), 0.92 (s, 9H, t-Bu-H), 0.07 (s, 6H, CH3 ).13 C-NMR (CDCl3 , 100MHz): δ188.7, 151.3, 148.5, 135.0, 128.9, 128.7(2C), 128.4(2C), 121.9, 121.1, 113.7, 71.4, 25.7(3C), 18.7, -4.3 (2C). MS (ESI): 421.1, 423.1 (M+H)+ .
3.步骤33. Step 3
50mL两口瓶回流装置中,氩气保护下加入化合物20(2.21mg,5.24mmol),Pd(dppf)Cl2(58mg,0.08mmol),无水1,4-二氧六环(15mL),二甲基锌(5.2mL,6.29mmol,1.2m/L)后,加热回流(110℃),反应1h。1N盐酸(50mL)淬灭反应,乙酸乙酯(2x50mL)萃取,合并有机相后,水洗,饱和食盐水洗,无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=40∶1(Rf=0.57,PE∶EA=15∶1),得1.53g化合物21,收率82%。In the reflux device of a 50mL two-necked flask, compound 20 (2.21mg, 5.24mmol), Pd(dppf)Cl2 (58mg, 0.08mmol), anhydrous 1,4-dioxane (15mL), and dioxane were added under argon protection. After methylzinc (5.2mL, 6.29mmol, 1.2m/L), heat to reflux (110°C) and react for 1h. Quench the reaction with 1N hydrochloric acid (50 mL), extract with ethyl acetate (2x50 mL), combine the organic phases, wash with water, wash with saturated brine, dry over anhydrous Na2 SO4 , filter, concentrate, column chromatography PE:EA=40:1 (Rf =0.57, PE:EA=15:1), 1.53 g of compound 21 was obtained, with a yield of 82%.
1H-NMR(CDCl3,400MHz):δ10.46(s,1H,CHO),7.44-7.35(m,5H,Ar-H),7.21(d,J=1.2Hz,1H,Ar-H),6.94(d,J=2.0Hz,1H,Ar-H),5.05(s,2H,CH2),2.28(s,3H,CH3),0.94(s,9H,t-Bu-H),0.08(s,6H,CH3).13C-NMR(CDCl3,100MHz):δ190.5,150.1,147.1,136.0,130.9,128.5(2C),128.3,128.2(2C),127.7,119.7,119.2,71.0,25.8(3C),20.9,18.8,-4.3(2C).MS(ESI):357.2(M+H)+.1 H-NMR (CDCl3 , 400MHz): δ10.46 (s, 1H, CHO), 7.44-7.35 (m, 5H, Ar-H), 7.21 (d, J=1.2Hz, 1H, Ar-H) , 6.94 (d, J=2.0Hz, 1H, Ar-H), 5.05 (s, 2H, CH2 ), 2.28 (s, 3H, CH3 ), 0.94 (s, 9H, t-Bu-H), 0.08(s, 6H, CH3 ).13 C-NMR (CDCl3 , 100MHz): δ190.5, 150.1, 147.1, 136.0, 130.9, 128.5(2C), 128.3, 128.2(2C), 127.7, 119.7, 119.2 , 71.0, 25.8(3C), 20.9, 18.8, -4.3(2C). MS(ESI): 357.2(M+H)+ .
4.步骤44. Step 4
50mL单口瓶中加入化合物21(891mg,2.50mmol),加入甲醇(25mL),冰浴下加入NaBH4(378mg,10.0mmol),再在室温下反应4h。减压浓缩,将得到的白色固体溶于3N盐酸(50mL),二氯甲烷(3x50mL)萃取,合并有机相,水(3x50mL)洗,饱和食盐水洗,无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=10∶1(Rf=0.41,PE∶EA=10∶1),得812mg化合物22,收率91%。Compound 21 (891mg, 2.50mmol) was added to a 50mL single-necked bottle, methanol (25mL) was added, NaBH4 (378mg, 10.0mmol) was added under ice-cooling, and the reaction was continued at room temperature for 4h. Concentrate under reduced pressure, dissolve the resulting white solid in 3N hydrochloric acid (50mL), extract with dichloromethane (3x50mL), combine the organic phases, wash with water (3x50mL), wash with saturated brine, dry over anhydrous Na2 SO4 , filter, and concentrate , column chromatography PE: EA = 10: 1 (Rf = 0.41, PE: EA = 10: 1), to obtain 812 mg of compound 22 with a yield of 91%.
1H-NMR(CDCl3,400MHz):δ7.42-7.30(m,5H,Ar-H),6.75(s,1H,Ar-H),6.68(s,1H,Ar-H),5.02(s,2H,CH2),4.67(s,2H,CH2),2.26(s,3H,CH3),2.23(s,1H,OH),0.94(s,9H,t-Bu-H),0.06(s,6H,CH3).13C-NMR(CDCl3,100MHz):δ148.9,140.1,136.5,132.0,130.7,128.4(2C),128.2(2C),128.0,121.0,113.1,70.6,61.7,25.9(3C),21.0,18.6,-4.0(2C).MS(ESI):381.2(M+Na)+.1 H-NMR (CDCl3 , 400MHz): δ7.42-7.30 (m, 5H, Ar-H), 6.75 (s, 1H, Ar-H), 6.68 (s, 1H, Ar-H), 5.02( s, 2H, CH2 ), 4.67 (s, 2H, CH2 ), 2.26 (s, 3H, CH3 ), 2.23 (s, 1H, OH), 0.94 (s, 9H, t-Bu-H), 0.06(s, 6H, CH3 ).13 C-NMR (CDCl3 , 100MHz): δ148.9, 140.1, 136.5, 132.0, 130.7, 128.4(2C), 128.2(2C), 128.0, 121.0, 113.1, 70.6 , 61.7, 25.9 (3C), 21.0, 18.6, -4.0 (2C). MS (ESI): 381.2 (M+Na)+ .
5.步骤55. Step 5
25mL单口瓶中加入化合物22(323mg,0.90mmol),加入四氢呋喃(9mL),冰浴下加入四丁基氟化铵(471mg,1.80mmol),后室温下反应0.5h。加水(20mL)稀释,乙酸乙酯(3x20mL)萃取,合并有机相,水洗,饱和食盐水洗,无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=4∶1(Rf=0.26,PE∶EA=4∶1),得206mg化合物23,收率94%。Compound 22 (323mg, 0.90mmol) was added to a 25mL single-necked bottle, tetrahydrofuran (9mL) was added, tetrabutylammonium fluoride (471mg, 1.80mmol) was added under ice-cooling, and then reacted at room temperature for 0.5h. Dilute with water (20 mL), extract with ethyl acetate (3x20 mL), combine the organic phases, wash with water, wash with saturated brine, dry over anhydrous Na2 SO4 , filter, concentrate, column chromatography PE:EA=4:1 (Rf = 0.26, PE:EA=4:1), to obtain 206mg of compound 23, yield 94%.
1H-NMR(CDCl3,400MHz):δ7.43-7.37(m,5H,Ar-H),6.73(s,1H,Ar-H),6.70(s,1H,Ar-H),5.91(s,1H,OH),5.09(s,2H,CH2),4.70(s,2H,CH2),2.36(s,1H,OH),2.28(s,3H,CH3).13C-NMR(CDCl3,100MHz):δ145.4,141.5,136.3,129.2,128.7(2C),128.3,127.8(2C),126.3,121.5,112.6,71.1,61.8,21.0.MS(ESI):267.1(M+Na)+.1 H-NMR (CDCl3 , 400MHz): δ7.43-7.37(m, 5H, Ar-H), 6.73(s, 1H, Ar-H), 6.70(s, 1H, Ar-H), 5.91( s, 1H, OH), 5.09 (s, 2H, CH2 ), 4.70 (s, 2H, CH2 ), 2.36 (s, 1H, OH), 2.28 (s, 3H, CH3 ).13 C-NMR (CDCl3 , 100MHz): δ145.4, 141.5, 136.3, 129.2, 128.7(2C), 128.3, 127.8(2C), 126.3, 121.5, 112.6, 71.1, 61.8, 21.0. MS(ESI): 267.1(M+ Na)+ .
6.步骤66. Step 6
50mL单口瓶中加入化合物23(892mg,3.66mmol),后用干燥的二氯甲烷(20mL)溶解,再加入对甲苯磺酸(70mg,0.37mmol),冰盐浴中搅拌15min后,滴加3,4-二氢-2H-吡喃(0.35mL,3.84mmol),反应1h。停止反应,加入三乙胺(1mL)淬灭反应,有机相饱和食盐水(10mL)洗,无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=20∶1(Rf=0.67,PE∶EA=4∶1)得1.01g化合物24,收率84%。Compound 23 (892mg, 3.66mmol) was added to a 50mL single-necked bottle, and then dissolved with dry dichloromethane (20mL), then p-toluenesulfonic acid (70mg, 0.37mmol) was added, stirred in an ice-salt bath for 15min, and then added dropwise with 3 , 4-dihydro-2H-pyran (0.35 mL, 3.84 mmol), reacted for 1 h. Stop the reaction, add triethylamine (1 mL) to quench the reaction, wash the organic phase with saturated brine (10 mL), dry over anhydrous Na2 SO4 , filter, concentrate, column chromatography PE:EA=20:1 (Rf = 0.67, PE:EA=4:1) to obtain 1.01 g of compound 24 with a yield of 84%.
1H-NMR(CDCl3,400MHz):δ7.44-7.34(m,5H,Ar-H),6.74(s,1H,Ar-H),6.71(s,1H,Ar-H),6.23(s,1H,OH),5.08(s,2H,CH2),4.82(d,J=12Hz,1H,CH2),4.75(t,J=3.3Hz,1H,CH),4.58(d,J=12Hz,1H,CH2),4.00-3.94(m,1H,CH2),3.59-3.56(m,1H,CH2),2.26(s,3H,CH3),1.88-1.53(m,6H).MS(ESI):351.1(M+Na)+.1 H-NMR (CDCl3 , 400MHz): δ7.44-7.34(m, 5H, Ar-H), 6.74(s, 1H, Ar-H), 6.71(s, 1H, Ar-H), 6.23( s, 1H, OH), 5.08 (s, 2H,CH2 ), 4.82 (d, J = 12Hz, 1H,CH2 ), 4.75 (t, J = 3.3Hz, 1H, CH), 4.58 (d, J =12Hz, 1H, CH2 ), 4.00-3.94 (m, 1H, CH2 ), 3.59-3.56 (m, 1H, CH2 ), 2.26 (s, 3H, CH3 ), 1.88-1.53 (m, 6H ). MS (ESI): 351.1 (M+Na)+ .
7.步骤77. Step 7
100mL两口瓶回流装置中,加入实施例1步骤9所得化合物9(1.11g,4.08mmol),化合物24(1.61g,4.89mmol),Cu(0.653g,10.2mmol),CuO(0.816g,10.2mmol),DMAP(1.49g,12.2mmol),氩气保护下加入CH3CN(30mL)后加热至回流,反应12h后停止反应,冷却,DCM稀释(20mL),过滤,浓缩,柱层析PE∶EA=6∶1(Rf=0.09,PE∶EA=10∶1)得1.27g化合物25,收率60%。In the 100mL two-necked flask reflux device, add compound 9 (1.11g, 4.08mmol) obtained in step 9 of Example 1, compound 24 (1.61g, 4.89mmol), Cu (0.653g, 10.2mmol), CuO (0.816g, 10.2mmol ), DMAP (1.49g, 12.2mmol), added CH3 CN (30mL) under the protection of argon and heated to reflux, stopped the reaction after 12h of reaction, cooled, diluted with DCM (20mL), filtered, concentrated, column chromatography PE: EA=6:1 (Rf =0.09, PE:EA=10:1) yielded 1.27 g of compound 25, yield 60%.
1H-NMR(CDCl3,400MHz):δ10.22(s,1H,CHO),7.76(d,J=8.7Hz,1H,Ar-H),7.28-7.16(m,5H,Ar-H),6.94(s,1H,Ar-H),6.83(s,1H,Ar-H),6.46(d,J=9.1Hz,1H,Ar-H),5.00(s,2H,CH2),4.69(d,J=12Hz,1H,CH2),4.68-4.67(m,1H,CH),4.43(d,J=12Hz,1H,CH2),3.99(s,3H,OCH3),3.95(s,3H,OCH3),3.83-3.76(m,1H,CH2),3.51-3.46(m,1H,CH2),2.36(s,3H,CH3),1.66-1.41(m,6H).13C-NMR(CDCl3,100MHz):δ187.7,165.3,161.7,161.5,150.1,138.3,136.5,136.4,132,2,131.0,128.2(2C),127.6,126.7(2C),122.9,122.5,117.8,114.9,110.3,98.4,70.4,64.7,64.3,61.8,52.6,30.2,25.3,21.4,19.0.MS(ESI):543.4(M+Na)+.HRMS(ESI):Calcd.for C30H32O8Na+(M+Na)+:543.1995,found:543.1968.1 H-NMR (CDCl3 , 400MHz): δ10.22 (s, 1H, CHO), 7.76 (d, J=8.7Hz, 1H, Ar-H), 7.28-7.16 (m, 5H, Ar-H) , 6.94 (s, 1H, Ar-H), 6.83 (s, 1H, Ar-H), 6.46 (d, J=9.1Hz, 1H, Ar-H), 5.00 (s, 2H, CH2 ), 4.69 (d, J=12Hz, 1H, CH2 ), 4.68-4.67 (m, 1H, CH), 4.43 (d, J=12Hz, 1H, CH2 ), 3.99 (s, 3H, OCH3 ), 3.95 ( s, 3H, OCH3 ), 3.83-3.76 (m, 1H, CH2 ), 3.51-3.46 (m, 1H, CH2 ), 2.36 (s, 3H, CH3 ), 1.66-1.41 (m, 6H) .13 C-NMR (CDCl3 , 100MHz): δ187.7, 165.3, 161.7, 161.5, 150.1, 138.3, 136.5, 136.4, 132, 2, 131.0, 128.2(2C), 127.6, 126.7(2C), 122.9, 122.5, 117.8, 114.9, 110.3, 98.4, 70.4, 64.7, 64.3, 61.8, 52.6, 30.2, 25.3, 21.4, 19.0. MS(ESI): 543.4(M+Na)+ .HRMS(ESI): Calcd.for C30 H32 O8 Na+ (M+Na)+ : 543.1995, found: 543.1968.
8.步骤88. Step 8
100mL的单口瓶中加入化合物25(1.23g,2.37mmol),对甲苯磺酸(3mg),后加入异丙醇(10mL)和H2O(3mL),加热回流过夜,停止反应,冷却,加入H2O(10mL),乙酸乙酯萃取(3x30mL),有机相水洗,饱和食盐水洗,无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=3∶1(Rf=0.20,PE∶EA=3∶1)得960mg化合物26,收率93%。Add compound 25 (1.23g, 2.37mmol), p-toluenesulfonic acid (3mg) into a 100mL single-necked bottle, then add isopropanol (10mL) and H2 O (3mL), heat and reflux overnight, stop the reaction, cool, add H2 O (10 mL), extracted with ethyl acetate (3x30 mL), washed the organic phase with water, washed with saturated brine, dried over anhydrous Na2 SO4 , filtered, concentrated, column chromatography PE:EA=3:1 (Rf =0.20 , PE:EA=3:1) to obtain 960 mg of compound 26 with a yield of 93%.
1H-NMR(CDCl3,400MHz):δ10.22(s,1H,CHO),7.74(d,J=9.0Hz,1H,Ar-H),7.29-7.16(m,5H,Ar-H),6.88(s,1H,Ar-H),6.83(s,1H,Ar-H),6.46(d,J=9.0Hz,1H,Ar-H),5.02(s,2H,CH2),4.56(s,2H,CH2),3.40(s,3H,OCH3),3.96(s,3H,OCH3),2.78(br s,1H,OH),2.35(s,3H,CH3).13C-NMR(CDCl3,100MHz):δ187.7,165.6,161.9,160.9,150.2,138.0,136.8,136.3,134.6,131.6,128.3(2C),127.7,126.7(2C),123.3,121.9,117.4,114.7,109.9,70.5,64.7,60.7,52.9,21.4.MS(ESI):459.3(M+Na)+.HRMS(ESI):Calcd.for C25H24O7Na+(M+Na)+:459.1420,found:459.1409.1 H-NMR (CDCl3 , 400MHz): δ10.22 (s, 1H, CHO), 7.74 (d, J=9.0Hz, 1H, Ar-H), 7.29-7.16 (m, 5H, Ar-H) , 6.88(s, 1H, Ar-H), 6.83(s, 1H, Ar-H), 6.46(d, J=9.0Hz, 1H, Ar-H), 5.02(s, 2H, CH2 ), 4.5613____ C-NMR (CDCl3 , 100MHz): δ187.7, 165.6, 161.9, 160.9, 150.2, 138.0, 136.8, 136.3, 134.6, 131.6, 128.3(2C), 127.7, 126.7(2C), 123.3, 121.9, 117.4, 114.7, 109.9, 70.5, 64.7, 60.7, 52.9, 21.4. MS (ESI): 459.3 (M+Na)+ . HRMS (ESI): Calcd. for C25 H24 O7 Na+ (M + Na)+ : 459.1420, found: 459.1409.
9.步骤99. Step 9
50mL单口瓶中加入化合物26(912mg,2.09mmol),用MeOH溶解(12mL),加入对甲苯磺酸(80mg,0.42mmol),室温搅拌1h后,加入NaOH(940mg,23.5mmol),加热至回流,反应过夜。停止反应,冷却,减压浓缩除去MeOH,用3N HCl调pH值至3,乙酸乙酯萃取(4x30mL),无水Na2SO4干燥,过滤,浓缩,得837mg化合物27粗品。Add compound 26 (912mg, 2.09mmol) to a 50mL single-necked bottle, dissolve (12mL) with MeOH, add p-toluenesulfonic acid (80mg, 0.42mmol), stir at room temperature for 1h, add NaOH (940mg, 23.5mmol), and heat to reflux , reacted overnight. The reaction was stopped, cooled, concentrated under reduced pressure to remove MeOH, adjusted to pH 3 with 3N HCl, extracted with ethyl acetate (4x30 mL), dried over anhydrous Na2 SO4 , filtered, and concentrated to obtain 837 mg of crude compound 27.
1H-NMR(DMSO,400MHz):δ10.11(s,1H,CHO),7.67(d,J=8.8Hz,1H,Ar-H),7.25-7.18(m,5H,Ar-H),7.03(s,1H,Ar-H),6.98(s,1H,Ar-H),6.38(d,J=8.8Hz,1H,Ar-H),5.08(s,2H,CH2),4.37(s,2H,CH2),3.97(s,3H,OCH3),2.34(s,3H,CH3).MS(ESI):421.0(M-H)-.1 H-NMR (DMSO, 400MHz): δ10.11 (s, 1H, CHO), 7.67 (d, J=8.8Hz, 1H, Ar-H), 7.25-7.18 (m, 5H, Ar-H), 7.03(s, 1H, Ar-H), 6.98(s, 1H, Ar-H), 6.38(d, J=8.8Hz, 1H, Ar-H), 5.08(s, 2H,CH2 ), 4.37( s, 2H, CH2 ), 3.97 (s, 3H, OCH3 ), 2.34 (s, 3H, CH3 ). MS (ESI): 421.0 (MH)- .
10.步骤1010. Step 10
将化合物27的粗品(837mg,1.98mmol)和三乙胺(2.2mL,15.8mmol)溶于干燥的CH3CN(20mL)中,将上述制得的溶液室温下缓慢滴加到由碘化-2-氯-1-甲基吡啶(2.02g,7.92mmol)溶于干燥的CH3CN(20mL)所配置的溶液中。滴加完毕后,加热回流反应过夜。停止反应,冷却,减压浓缩除去CH3CN,加入H2O(20mL),DCM萃取(3x30mL),无水Na2SO4干燥,过滤,浓缩,柱层析DCM(Rf=0.80,PE∶EA=2∶1)得407mg化合物28,两步合计收率51%。The crude product of compound 27 (837mg, 1.98mmol) and triethylamine (2.2mL, 15.8mmol) were dissolved in dry CH3 CN (20mL), and the solution prepared above was slowly added dropwise at room temperature to the iodide- 2-Chloro-1-picoline (2.02 g, 7.92 mmol) was dissolved in dryCH3CN (20 mL). After the dropwise addition was completed, the reaction was heated to reflux overnight. The reaction was stopped, cooled, concentrated under reduced pressure to remove CH3 CN, added H2 O (20 mL), extracted with DCM (3x30 mL), dried over anhydrous Na2 SO4 , filtered, concentrated, column chromatography DCM (Rf =0.80, PE :EA=2:1) to obtain 407mg of compound 28, the total yield of the two steps was 51%.
1H-NMR(CDCl3,400MHz):δ10.35(d,J=0.6Hz,1H,CHO),7.98(d,J=8.6Hz,1H,Ar-H),7.51-7.35(m,5H,Ar-H),7.03(dd,J=8.6,0.6Hz,1H,Ar-H),6.89(d,J=1.5Hz,1H,Ar-H),6.48(d,J=1.2Hz,1H,Ar-H),5.20(s,2H,CH2),5.13(s,2H,CH2),4.12(s,3H,OCH3),2.28(s,3H,CH3).13C-NMR(CDCl3,100MHz):δ187.8,166.1,161.2,158.0,150.4,143.2,136.5,135.3,133.3,128.7(2C),128.1,127.32,127.27(2C),127.0,121.5,120.6,118.7,116.6,71.3,69.0,64.7,21.2.MS(ESI):427.0(M+Na)+.HRMS(ESI):Calcd.for C24H20O6Na+(M+Na)+:427.1158,found:427.1133.1 H-NMR (CDCl3 , 400MHz): δ10.35 (d, J=0.6Hz, 1H, CHO), 7.98 (d, J=8.6Hz, 1H, Ar-H), 7.51-7.35 (m, 5H , Ar-H), 7.03 (dd, J=8.6, 0.6Hz, 1H, Ar-H), 6.89 (d, J=1.5Hz, 1H, Ar-H), 6.48 (d, J=1.2Hz, 1H , Ar-H), 5.20 (s, 2H, CH2 ), 5.13 (s, 2H, CH2 ), 4.12 (s, 3H, OCH3 ), 2.28 (s, 3H, CH3 ).13 C-NMR (CDCl3 , 100MHz): δ187.8, 166.1, 161.2, 158.0, 150.4, 143.2, 136.5, 135.3, 133.3, 128.7(2C), 128.1, 127.32, 127.27(2C), 127.0, 121.5, 120.6, 1168.7, , 71.3, 69.0, 64.7, 21.2.MS(ESI): 427.0(M+Na)+ .HRMS(ESI): Calcd.for C24 H20 O6 Na+ (M+Na)+ : 427.1158, found: 427.1133 .
11.步骤1111. Step 11
25mL单口瓶中加入化合物28(262mg,0.65mmol),氩气保护下,加入干燥的THF(10mL),冰浴下滴加新戊基溴化镁(1.5mL,3.9mmol),后自然升温至室温搅拌1h,加入饱和NH4Cl淬灭反应,EA萃取(3x30mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=5∶1(Rf=0.44,PE∶EA=3∶1)得305mg化合物29,收率98%。Compound 28 (262mg, 0.65mmol) was added to a 25mL single-necked bottle, under the protection of argon, dry THF (10mL) was added, and neopentylmagnesium bromide (1.5mL, 3.9mmol) was added dropwise under ice-cooling, and then the temperature was naturally raised to Stir at room temperature for 1 h, add saturated NH4 Cl to quench the reaction, extract with EA (3x30 mL), dry over anhydrous Na2 SO4 , filter, concentrate, column chromatography PE:EA=5:1 (Rf =0.44, PE:EA =3:1) to obtain 305mg of compound 29, the yield was 98%.
1H-NMR(CDCl3,400MHz):δ7.57(d,J=8.2Hz,1H,Ar-H),7.51-7.49(m,2H,Ar-H),7.42-7.31(m,3H,Ar-H),6.94(d,J=7.8Hz,1H,Ar-H),6.85(s,1H,Ar-H),6.44(s,1H,Ar-H),5.19(s,2H,CH2),5.18-5.14(m,1H,CH),5.08(s,2H,CH2),3.95(s,3H,OCH3),2.25(s,3H,CH3),2.12(br s,1H,OH),1.68-1.53(m,2H,CH2),1.02(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ167.5,153.9,152.0,150.2,144.0,137.5,136.7,134.4,130.9,128.5(2C),127.9,127.23,127.16(2C),121.6,119.3,118.0,116.5,71.2,69.0,66.3,62.5,52.1,30.6,30.0(3C),21.0.MS(ESI):477.2(M+H)+.HRMS(APCI):Calcd.for C29H33O6+(M+H)+:477.2277,found:477.2278.1 H-NMR (CDCl3 , 400MHz): δ7.57 (d, J=8.2Hz, 1H, Ar-H), 7.51-7.49 (m, 2H, Ar-H), 7.42-7.31 (m, 3H, Ar-H), 6.94(d, J=7.8Hz, 1H, Ar-H), 6.85(s, 1H, Ar-H), 6.44(s, 1H, Ar-H), 5.19(s, 2H, CH2 ), 5.18-5.14(m, 1H, CH), 5.08(s, 2H, CH2 ), 3.95(s, 3H, OCH3 ), 2.25(s, 3H, CH3 ), 2.12(br s, 1H , OH), 1.68-1.53 (m, 2H, CH2 ), 1.02 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ167.5, 153.9, 152.0, 150.2, 144.0, 137.5, 136.7, 134.4, 130.9, 128.5(2C), 127.9, 127.23, 127.16(2C), 121.6, 119.3, 118.0, 116.5, 71.2, 69.0, 66.3, 62.5, 52.1, 30.6, 30.0(3C) .MS(ESI): 477.2(M+H)+ .HRMS(APCI): Calcd.for C29 H33 O6+ (M+H)+ : 477.2277, found: 477.2278.
12.步骤1212. Step 12
50mL单口瓶中加入化合物29(130mg,0.27mmol),DMSO溶解(10mL),后加入IBX(151mg,0.54mmol),室温搅拌过夜,停止反应,加入H2O(10mL),DCM萃取(4x20mL),有机相水洗(1x50mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=7∶1(Rf=0.51,PE∶EA=3∶1)得123mg化合物30,收率96%。Add compound 29 (130mg, 0.27mmol) to a 50mL single-necked bottle, dissolve in DMSO (10mL), then add IBX (151mg, 0.54mmol), stir at room temperature overnight, stop the reaction, add H2 O (10mL), extract with DCM (4x20mL) , the organic phase was washed with water (1x50mL), dried over anhydrous Na2 SO4 , filtered, concentrated, column chromatography PE: EA = 7: 1 (Rf = 0.51, PE: EA = 3: 1) to obtain 123 mg of compound 30, yield The rate is 96%.
1H-NMR(CDCl3,400MHz):δ7.59(d,J=8.6Hz,1H,Ar-H),7.50-7.48(m,2H,Ar-H),7.42-7.33(m,3H,Ar-H),6.98(d,J=8.6Hz,1H,Ar-H),6.87(d,J=1.2Hz,1H,Ar-H),6.47(s,1H,Ar-H),5.19(s,2H,CH2),5.11(s,2H,CH2),3.94(s,3H,OCH3),2.90(s,2H,CH2),2.26(s,3H,CH3),1.00(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ202.2,166.3,156.5,155.1,150.3,143.4,136.6,134.9,133.6,133.5,128.6(2C),128.0,127.24,127.20(2C),121.6,120.7,118.4,116.6,71.2,68.9,63.7,54.7,31.6,29.8(3C),21.1.MS(ESI):475.3(M+H)+.HRMS(APCI):Calcd.forC29H31O6+(M+H)+:475.2121,found:475.2082.1 H-NMR (CDCl3 , 400MHz): δ7.59 (d, J=8.6Hz, 1H, Ar-H), 7.50-7.48 (m, 2H, Ar-H), 7.42-7.33 (m, 3H, Ar-H), 6.98(d, J=8.6Hz, 1H, Ar-H), 6.87(d, J=1.2Hz, 1H, Ar-H), 6.47(s, 1H, Ar-H), 5.19( s, 2H, CH2 ), 5.11 (s, 2H, CH2 ), 3.94 (s, 3H, OCH3 ), 2.90 (s, 2H, CH2 ), 2.26 (s, 3H, CH3 ), 1.00 ( s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ202.2, 166.3, 156.5, 155.1, 150.3, 143.4, 136.6, 134.9, 133.6, 133.5, 128.6 (2C), 128.0 , 127.24, 127.20(2C), 121.6, 120.7, 118.4, 116.6, 71.2, 68.9, 63.7, 54.7, 31.6, 29.8(3C), 21.1.MS(ESI): 475.3(M+H)+ .HRMS(APCI) : Calcd.forC29 H31 O6+ (M+H)+ : 475.2121, found: 475.2082.
13.步骤1313. Step 13
氩气保护下,在50mL单口瓶中加入(R)-Me-CBS(186μL,0.186mmol),减压除去其中的甲苯,再加入THF(9mL)。降温至-20℃,加入BH3·THF(0.68mL,0.68mmol,1M in THF),后缓慢滴加化合物30(294mg,0.62mmol)的THF溶液(9mL),3h滴加完毕。-20℃反应4h后停止反应,加入H2O(3mL)淬灭反应,EA萃取(3x15mL),有机相水洗,无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=5∶1得250mg化合物31,收率85%,ee值88%。(手性柱拆分条件:PC-2柱,UV 214nm,正己烷∶异丙醇=50∶50,0.5mL/min)Under the protection of argon, (R)-Me-CBS (186 μL, 0.186 mmol) was added to a 50 mL single-necked flask, the toluene was removed under reduced pressure, and then THF (9 mL) was added. Cool down to -20°C, add BH3 ·THF (0.68mL, 0.68mmol, 1M in THF), and then slowly add compound 30 (294mg, 0.62mmol) in THF solution (9mL) dropwise for 3h. Stop the reaction after reacting at -20°C for 4 h, add H2 O (3 mL) to quench the reaction, extract with EA (3x15 mL), wash the organic phase with water, dry over anhydrous Na2 SO4 , filter, concentrate, column chromatography PE:EA=5 : 1 to obtain 250 mg of compound 31 with a yield of 85% and an ee value of 88%. (Chiral column resolution conditions: PC-2 column, UV 214nm, n-hexane:isopropanol=50:50, 0.5mL/min)
[α]D20=+7.3°(C=4.4,CHCl3).[α]D20 =+7.3° (C=4.4, CHCl3 ).
14.步骤1414. Step 14
50mL单口瓶中加入化合物31(165mg,0.35mmol),用EtOH(3mL)和EA(7mL)的混合溶液溶解后加入钯碳(17mg),通入H2,TLC监测至原料消失,过滤,浓缩,柱层析PE∶EA=3∶1(Rf=0.42,PE∶EA=2∶1)得117mg化合物32,收率87%。Add compound 31 (165mg, 0.35mmol) to a 50mL single-necked bottle, dissolve it with a mixed solution of EtOH (3mL) and EA (7mL), add palladium carbon (17mg), feed H2 , monitor by TLC until the raw material disappears, filter, and concentrate , column chromatography PE: EA = 3: 1 (Rf = 0.42, PE: EA = 2: 1) yielded 117 mg of compound 32, with a yield of 87%.
1H-NMR(CDCl3,400MHz):δ7.52(d,J=8.7Hz,1H,Ar-H),6.84(s,1H,Ar-H),6.81(d,J=8.7Hz,1H,Ar-H),6.76(br s,1H,OH),6.34(s,1H,Ar-H),5.15-5.04(m,3H),3.96(s,3H,OCH3),2.31(br s,1H,OH),2.23(s,3H,CH3),1.64-1.50(m,2H,CH2),1.01(s,9H,t-Bu-H).MS(ESI):387.0(M+H)+.,[α]D20=+9.7°(C=3.2,CHCl3)1 H-NMR (CDCl3 , 400MHz): δ7.52(d, J=8.7Hz, 1H, Ar-H), 6.84(s, 1H, Ar-H), 6.81(d, J=8.7Hz, 1H , Ar-H), 6.76(br s, 1H, OH), 6.34(s, 1H, Ar-H), 5.15-5.04(m, 3H), 3.96(s, 3H, OCH3 ), 2.31(br s , 1H, OH), 2.23 (s, 3H, CH3 ), 1.64-1.50 (m, 2H, CH2 ), 1.01 (s, 9H, t-Bu-H). MS (ESI): 387.0 (M+ H)+ ., [α]D20 =+9.7° (C=3.2, CHCl3 )
15.步骤1515. Step 15
50mL单口瓶中加入化合物32(161mg,0.42mmol)和干燥的THF(10mL),后加入NaH(18mg,0.46mmol),室温搅拌1h,后缓慢滴加对溴苯甲酰氯(101mg,0.46mmol)的THF(10mL)溶液,过夜后停止反应,直接柱层析PE∶EA=5∶1(Rf=0.25,PE∶EA=3∶1)得219mg化合物33,收率92%。Add compound 32 (161mg, 0.42mmol) and dry THF (10mL) into a 50mL single-necked bottle, then add NaH (18mg, 0.46mmol), stir at room temperature for 1h, then slowly add p-bromobenzoyl chloride (101mg, 0.46mmol) dropwise The solution in THF (10 mL) was stopped overnight, and direct column chromatography PE:EA=5:1 (Rf =0.25, PE:EA=3:1) gave 219 mg of compound 33, with a yield of 92%.
1H-NMR(CDCl3,400MHz):δ8.13-8.10(m,2H,Ar-H),7.69-7.66(m,2H,Ar-H),7.57(d,J=8.6Hz,1H,Ar-H),7.07(s,1H,Ar-H),6.94(d,J=8.6Hz,1H,Ar-H),6.81(s,1H,Ar-H),5.15-5.11(m,3H),3.95(s,3H,OCH3),2.32(s,3H,CH3),1.86(br s,1H,OH),1.67-1.52(m,2H,CH2),1.01(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ167.0,164.7,153.9,151.1,145.7,141.9,138.1,134.5,132.0,131.7,131.0,129.2,128.0,127.8,127.2,124.8,119.5,118.2,69.0,66.4,62.9,52.2,30.7,30.0(3C),20.6.HRMS(APCI):Calcd.for C29H28BrO7-(M-H)-:567.1019,found:567.1037,[α]D20=-3.1°(C=1.0,CHCl3).1 H-NMR (CDCl3 , 400MHz): δ8.13-8.10 (m, 2H, Ar-H), 7.69-7.66 (m, 2H, Ar-H), 7.57 (d, J=8.6Hz, 1H, Ar-H), 7.07(s, 1H, Ar-H), 6.94(d, J=8.6Hz, 1H, Ar-H), 6.81(s, 1H, Ar-H), 5.15-5.11(m, 3H ), 3.95(s, 3H, OCH3 ), 2.32(s, 3H, CH3 ), 1.86(br s, 1H, OH), 1.67-1.52(m, 2H, CH2 ), 1.01(s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ167.0, 164.7, 153.9, 151.1, 145.7, 141.9, 138.1, 134.5, 132.0, 131.7, 131.0, 129.2, 128.0, 127.8, 127.2, 124.8, 119.5, 118.2, 69.0, 66.4, 62.9, 52.2, 30.7, 30.0 (3C), 20.6. HRMS (APCI): Calcd. for C29 H28 BrO7- (MH)- : 567.1019, found: 567.1037, [ α]D20 = -3.1° (C = 1.0, CHCl3 ).
实施例3:制备下述化合物,Embodiment 3: prepare following compound,
1.步骤11. Step 1
25mL单口瓶中加入实施例2步骤14所得化合物32(30mg,0.078mmol)和干燥的THF(2mL),后加入NaH(3.4mg,0.086mmol),室温搅拌1h,后缓慢滴加对三氟甲基苯甲酰氯(13μL,0.086mmol)的THF(2mL)溶液,过夜后停止反应,直接柱层析PE∶EA=5∶1(Rf=0.38,PE∶EA=3∶1)得32mg化合物34,收率73%。Add compound 32 (30mg, 0.078mmol) obtained in Step 14 of Example 2 and dry THF (2mL) into a 25mL single-mouth bottle, then add NaH (3.4mg, 0.086mmol), stir at room temperature for 1h, and then slowly add p-trifluoroform Benzoyl chloride (13μL, 0.086mmol) in THF (2mL) solution, stop the reaction overnight, direct column chromatography PE: EA = 5: 1 (Rf = 0.38, PE: EA = 3: 1) to give 32 mg of compound 34, yield 73%.
1H-NMR(CDCl3,400MHz):δ8.39-8.36(m,2H,Ar-H),7.81-7.78(m,2H,Ar-H),7.58(d,J=8.6Hz,1H,Ar-H),7.09(s,1H,Ar-H),6.94(d,J=8.2Hz,1H,Ar-H),6.83(s,1H,Ar-H),5.15-5.11(m,3H),3.95(s,3H,OCH3),2.33(s,3H,CH3),1.91(br s,1H,OH),1.67-1.51(m,2H,CH2),1.01(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ167.0,164.1,153.9,151.0,145.6,141.7,138.2,135.2(q,J=32Hz),134.5,132.1,131.0,130.6,128.1,127.2,125.7,124.8,124.7,119.4,118.1,68.9,66.3,62.8,52.2,30.6,30.0(3C),20.6.19F-NMR(CDCl3,376MHz):δ-63.6.HRMS(APCI):Calcd.for C30H28F3O7-(M-H)-:557.1787,found:557.1797,[α]D20=-8.4°(C=1.0,CHCl3).1 H-NMR (CDCl3 , 400MHz): δ8.39-8.36 (m, 2H, Ar-H), 7.81-7.78 (m, 2H, Ar-H), 7.58 (d, J=8.6Hz, 1H, Ar-H), 7.09(s, 1H, Ar-H), 6.94(d, J=8.2Hz, 1H, Ar-H), 6.83(s, 1H, Ar-H), 5.15-5.11(m, 3H ), 3.95(s, 3H, OCH3 ), 2.33(s, 3H, CH3 ), 1.91(br s, 1H, OH), 1.67-1.51(m, 2H, CH2 ), 1.01(s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ167.0, 164.1, 153.9, 151.0, 145.6, 141.7, 138.2, 135.2 (q, J=32Hz), 134.5, 132.1, 131.0, 130.6 , 128.1, 127.2, 125.7, 124.8, 124.7, 119.4, 118.1, 68.9, 66.3, 62.8, 52.2, 30.6, 30.0 (3C), 20.6.19 F-NMR (CDCl3 , 376MHz): δ-63.6.HRMS (APCI ): Calcd.for C30 H28 F3 O7- (MH)- : 557.1787, found: 557.1797, [α]D20 = -8.4° (C = 1.0, CHCl3 ).
实施例4:制备下述化合物,Example 4: Preparation of the following compounds,
1.步骤11. Step 1
25mL单口瓶中加入实施例2步骤14所得化合物32(30mg,0.078mmol)和干燥的THF(2mL),后加入NaH(3.4mg,0.086mmol),室温搅拌1h,后缓慢滴加3,5-二(三氟甲基)苯甲酰氯(16μL,0.086mmol)的THF(2mL)溶液,过夜后停止反应,直接柱层析PE∶EA=5∶1(Rf=0.45,PE∶EA=3∶1)得42mg化合物35,收率86%。Add compound 32 (30mg, 0.078mmol) obtained in step 14 of Example 2 and dry THF (2mL) into a 25mL one-mouth bottle, then add NaH (3.4mg, 0.086mmol), stir at room temperature for 1h, and then slowly add 3,5- Bis(trifluoromethyl)benzoyl chloride (16μL, 0.086mmol) in THF (2mL) solution, stop the reaction after overnight, direct column chromatography PE:EA=5:1 (Rf =0.45, PE:EA=3 : 1) 42 mg of compound 35 was obtained, with a yield of 86%.
1H-NMR(CDCl3,400MHz):δ8.70(s,2H,Ar-H),8.16(s,1H,Ar-H),7.61(d,J=8.6Hz,1H,Ar-H),7.09(s,1H,Ar-H),6.94(d,J=8.6Hz,1H,Ar-H),6.86(s,1H,Ar-H),5.16-5.12(m,3H),3.95(s,3H,OCH3),2.34(s,3H,CH3),1.93(br s,1H,OH),1.67-1.52(m,2H,CH2),1.01(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ166.9,162.7,153.9,150.9,145.5,141.3,138.4,134.6,132.5(q,J=33Hz),131.1,130.3,128.5,127.3,127.2,124.4,124.0,121.3,119.5,118.0,68.9,66.3,62.9,52.2,30.6,30.0(3C),20.6.19F-NMR(CDCl3,376MHz):δ-63.4.HRMS(APCI):Calcd.forC31H27F6O7-(M-H)-:625.1661,found:625.1649,[α]D20=-5.6°(C=1.0,CHCl3).1 H-NMR (CDCl3 , 400MHz): δ8.70(s, 2H, Ar-H), 8.16(s, 1H, Ar-H), 7.61(d, J=8.6Hz, 1H, Ar-H) , 7.09(s, 1H, Ar-H), 6.94(d, J=8.6Hz, 1H, Ar-H), 6.86(s, 1H, Ar-H), 5.16-5.12(m, 3H), 3.95( s, 3H, OCH3 ), 2.34 (s, 3H, CH3 ), 1.93 (br s, 1H, OH), 1.67-1.52 (m, 2H, CH2 ), 1.01 (s, 9H, t-Bu- H).13 C-NMR (CDCl3 , 100MHz): δ166.9, 162.7, 153.9, 150.9, 145.5, 141.3, 138.4, 134.6, 132.5 (q, J=33Hz), 131.1, 130.3, 128.5, 127.3, 127.2 , 124.4, 124.0, 121.3, 119.5, 118.0, 68.9, 66.3, 62.9, 52.2, 30.6, 30.0 (3C), 20.6.19 F-NMR (CDCl3 , 376MHz): δ-63.4. HRMS (APCI): Calcd. forC31 H27 F6 O7- (MH)- : 625.1661, found: 625.1649, [α]D20 = -5.6° (C = 1.0, CHCl3 ).
实施例5:制备下述化合物,Example 5: Preparation of the following compounds,
1.步骤11. Step 1
25mL单口瓶中加入实施例2步骤14所得化合物32(40mg,0.10mmol)和干燥的THF(2mL),后加入NaH(4.4mg,0.11mmol),室温搅拌1h,后缓慢滴加实施例1步骤18所得酰氯b(22mg,0.13mmol)的THF(2mL)溶液,过夜后停止反应,直接板层析PE∶EA=3∶1(Rf=0.46,PE∶EA=3∶1)得38mg化合物36,收率73%。Add compound 32 (40mg, 0.10mmol) obtained in step 14 of Example 2 and dry THF (2mL) into a 25mL one-mouth bottle, then add NaH (4.4mg, 0.11mmol), stir at room temperature for 1h, and then slowly add step 1 in Example 1 The THF (2mL) solution of the obtained acid chloride b (22mg, 0.13mmol) obtained in 18 stopped the reaction overnight, and direct plate chromatography PE:EA=3:1 (Rf =0.46, PE:EA=3:1) gave 38mg of the compound 36, yield 73%.
1H-NMR(CDCl3,400MHz):δ7.60(d,J=8.6Hz,1H,Ar-H),6.99(d,J=8.6Hz,1H,Ar-H),6.88(s,1H,Ar-H),6.74(s,1H,Ar-H),5.18-5.14(m,1H,CH),5.07(s,2H,CH2),3.97(s,3H,OCH3),2.33(s,2H),2.28(s,3H,CH3),1.98-1.84(m,5H),1.70-1.55(m,2H,CH2),1.45(s,3H,CH3),1.34-1.32(m,4H),1.02(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ175.4,167.2,153.8,151.3,146.1,141.8,138.1,134.2,131.1,127.6,127.1,124.7,119.7,118.3,69.1,66.3,62.9,58.6,52.2,41.9,30.7,30.1,29.3,27.7,20.5,17.1.HRMS(APCI):Calcd.for C31H37O7-(M-H)-:521.2540,found:521.2551,[α]D20=+2.4°(C=1.0,CHCl3).1 H-NMR (CDCl3 , 400MHz): δ7.60(d, J=8.6Hz, 1H, Ar-H), 6.99(d, J=8.6Hz, 1H, Ar-H), 6.88(s, 1H , Ar-H), 6.74 (s, 1H, Ar-H), 5.18-5.14 (m, 1H, CH), 5.07 (s, 2H, CH2 ), 3.97 (s, 3H, OCH3 ), 2.33 ( s, 2H), 2.28 (s, 3H, CH3 ), 1.98-1.84 (m, 5H), 1.70-1.55 (m, 2H, CH2 ), 1.45 (s, 3H, CH3 ), 1.34-1.32 ( m, 4H), 1.02 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ175.4, 167.2, 153.8, 151.3, 146.1, 141.8, 138.1, 134.2, 131.1, 127.6 , 127.1, 124.7, 119.7, 118.3, 69.1, 66.3, 62.9, 58.6, 52.2, 41.9, 30.7, 30.1, 29.3, 27.7, 20.5, 17.1. HRMS (APCI): Calcd.for C31 H37 O7- (MH )- : 521.2540, found: 521.2551, [α]D20 =+2.4° (C = 1.0, CHCl3 ).
实施例6:制备下述化合物,Example 6: Preparation of the following compounds,
1.步骤11. Step 1
50mL的两口瓶中加入实施例2步骤1所得化合物19(1.04g,3.40mmol),对甲氧基苯硼酸(620mg,4.08mmol),Pd(PPh3)4(347mg,0.34mmol),2N K2CO3(3.4mL,6.80mmol),甲醇(15mL),80℃反应过夜。反应液加硅藻土抽滤,加水稀释后乙酸乙酯萃取,有机相水洗,饱和食盐水洗,无水MgSO4干燥,过滤,浓缩,柱层析PE∶EA=10∶1(Rf=0.16,PE∶EA=10∶1)得950mg化合物37,收率84%。Compound 19 (1.04g, 3.40mmol) obtained in Step 1 of Example 2, p-methoxyphenylboronic acid (620mg, 4.08mmol), Pd(PPh3 )4 (347mg, 0.34mmol), 2N K2 CO3 (3.4mL, 6.80mmol), methanol (15mL), react at 80°C overnight. The reaction solution was filtered with diatomaceous earth, diluted with water, extracted with ethyl acetate, washed with water, washed with saturated brine, dried with anhydrous MgSO4 , filtered, concentrated, column chromatography PE:EA=10:1 (Rf =0.16 , PE:EA=10:1) to obtain 950 mg of compound 37 with a yield of 84%.
1H-NMR(CDCl3,400MHz):δ11.00(s,1H,OH),9.98(s,1H,CHO),7.49-7.47(m,2H,Ar-H),7.41-7.33(m,7H,Ar-H),6.97-6.95(m,2H,Ar-H),5.25(s,2H,CH2),3.85(s,3H,OCH3).13C-NMR(CDCl3,100MHz):δ196.5,159.1,151.1,147.3,136.4,132.8,132.0,128.6(2C),128.1,127.6(2C),127.4(2C),122.9,121.0,119.7,114.3(2C),71.5,55.3.MS(ESI):335.2(M+H)+.HRMS(APCI):Calcd.for C21H19O4+(M+H)+:335.1283,found:335.1262.1 H-NMR (CDCl3 , 400MHz): δ11.00(s, 1H, OH), 9.98(s, 1H, CHO), 7.49-7.47(m, 2H, Ar-H), 7.41-7.33(m, 7H, Ar-H), 6.97-6.95(m, 2H, Ar-H), 5.25(s, 2H, CH2 ), 3.85(s, 3H, OCH3 ).13 C-NMR (CDCl3 , 100MHz) : δ196.5, 159.1, 151.1, 147.3, 136.4, 132.8, 132.0, 128.6(2C), 128.1, 127.6(2C), 127.4(2C), 122.9, 121.0, 119.7, 114.3(2C), 71.5, 55.3.MS (ESI): 335.2(M+H)+ .HRMS(APCI): Calcd.for C21 H19 O4+ (M+H)+ : 335.1283, found: 335.1262.
2.步骤22. Step 2
100mL单口瓶中加入化合物37(950mg,2.84mmol),加入甲醇(30mL),冰浴下加入NaBH4(216mg,5.68mmol)后,室温下反应1h。减压浓缩,将得到的白色固体溶于3N盐酸,乙酸乙酯萃取,有机相水洗,饱和食盐水洗,无水MgSO4干燥,过滤,浓缩,柱层析PE∶EA=3∶1(Rf=0.21,PE∶EA=3∶1),得822mg化合物38,收率86%。Compound 37 (950 mg, 2.84 mmol) was added to a 100 mL single-necked bottle, methanol (30 mL) was added, NaBH4 (216 mg, 5.68 mmol) was added under ice-cooling, and the reaction was carried out at room temperature for 1 h. Concentrate under reduced pressure, dissolve the obtained white solid in 3N hydrochloric acid, extract with ethyl acetate, wash the organic phase with water, wash with saturated brine, dry with anhydrous MgSO4 , filter, concentrate, column chromatography PE: EA = 3: 1 (Rf =0.21, PE:EA=3:1), to obtain 822mg of compound 38, yield 86%.
1H-NMR(CDCl3,400MHz):δ7.45-7.44(m,7H,Ar-H),7.08-7.07(m,2H,Ar-H),6.96-6.94(m,2H,Ar-H),6.10(s,1H,OH),5.17(s,2H,CH2),4.79(s,2H,CH2),3.84(s,3H,OCH3),2.40(br s,1H,OH).13C-NMR(CDCl3,100MHz):δ158.7,145.8,143.0,136.2,133.5,132.9,128.7(2C),128.4,127.8(2C),127.7(2C),126.8,119.5,114.1(2C),110.5,71.3,61.8,55.3.MS(ESI):335.2(M-H)-.HRMS(APCI):Calcd.for C21H19O4-(M-H)-:335.1284,found:335.1261.1 H-NMR (CDCl3 , 400MHz): δ7.45-7.44 (m, 7H, Ar-H), 7.08-7.07 (m, 2H, Ar-H), 6.96-6.94 (m, 2H, Ar-H ), 6.10 (s, 1H, OH), 5.17 (s, 2H, CH2 ), 4.79 (s, 2H, CH2 ), 3.84 (s, 3H, OCH3 ), 2.40 (br s, 1H, OH) .13 C-NMR (CDCl3 , 100MHz): δ158.7, 145.8, 143.0, 136.2, 133.5, 132.9, 128.7(2C), 128.4, 127.8(2C), 127.7(2C), 126.8, 119.5, 114.1(2C ), 110.5, 71.3, 61.8, 55.3. MS (ESI): 335.2 (MH)- . HRMS (APCI): Calcd. for C21 H19 O4- (MH)- : 335.1284, found: 335.1261.
3.步骤33. Step 3
50mL单口瓶中加入化合物38(822mg,2.45mmol),后用干燥的二氯甲烷(20mL)溶解,再加入对甲苯磺酸(48mg,0.25mmol),冰盐浴中搅拌15min后,滴加3,4-二氢-2H-吡喃(0.23mL,2.52mmol),反应1h。停止反应,加入三乙胺(1mL)淬灭反应,有机相饱和食盐水洗,无水MgSO4干燥,过滤,浓缩,柱层析PE∶EA=7∶1(Rf=0.57,PE∶EA=3∶1)得949mg化合物39,收率92%。Compound 38 (822mg, 2.45mmol) was added to a 50mL single-necked bottle, and then dissolved with dry dichloromethane (20mL), then p-toluenesulfonic acid (48mg, 0.25mmol) was added, and after stirring for 15min in an ice-salt bath, 3 , 4-dihydro-2H-pyran (0.23 mL, 2.52 mmol), reacted for 1 h. Stop the reaction, add triethylamine (1 mL) to quench the reaction, wash the organic phase with saturated brine, dry over anhydrous MgSO4 , filter, concentrate, column chromatography PE:EA=7:1 (Rf =0.57, PE:EA= 3:1) to obtain 949 mg of compound 39 with a yield of 92%.
1H-NMR(CDCl3,400MHz):δ7.46-7.35(m,7H,Ar-H),7.12(d,J=1.6Hz,1H,Ar-H),7.07(d,J=2.0Hz,1H,Ar-H),6.95-6.92(m,2H,Ar-H),6.40(s,1H,OH),5.17(s,2H,CH2),4.90(d,J=12Hz,1H,CH2),4.79(t,J=3.5Hz,1H,CH),4.67(d,J=12Hz,1H,CH2),4.01-3.95(m,1H,CH2),3.83(s,3H,OCH3),3.60-3.56(m,1H,CH2),1.89-1.54(m,6H).13C-NMR(CDCl3,100MHz):δ158.6,146.2,143.6,136.5,133.7,132.6,128.6(2C),128.2,127.8(2C),127.7(2C),124.0,120.3,114.0(2C),111.0,98.2,71.3,64.9,62.5,55.3,30.5,25.3,19.5.MS(ESI):443.2(M+Na)+.HRMS(APCI):Calcd.for C26H27O5-(M-H)-:419.1859,found:419.1823.1 H-NMR (CDCl3 , 400MHz): δ7.46-7.35(m, 7H, Ar-H), 7.12(d, J=1.6Hz, 1H, Ar-H), 7.07(d, J=2.0Hz , 1H, Ar-H), 6.95-6.92(m, 2H, Ar-H), 6.40(s, 1H, OH), 5.17(s, 2H, CH2 ), 4.90(d, J=12Hz, 1H, CH2 ), 4.79(t, J=3.5Hz, 1H, CH), 4.67(d, J=12Hz, 1H, CH2 ), 4.01-3.95(m, 1H, CH2 ), 3.83(s, 3H, OCH3 ), 3.60-3.56 (m, 1H, CH2 ), 1.89-1.54 (m, 6H).13 C-NMR (CDCl3 , 100MHz): δ158.6, 146.2, 143.6, 136.5, 133.7, 132.6, 128.6(2C), 128.2, 127.8(2C), 127.7(2C), 124.0, 120.3, 114.0(2C), 111.0, 98.2, 71.3, 64.9, 62.5, 55.3, 30.5, 25.3, 19.5. MS(ESI): 443.2 (M+Na)+ .HRMS(APCI): Calcd.for C26 H27 O5- (MH)- : 419.1859, found: 419.1823.
4.步骤44. Step 4
50mL两口瓶回流装置中,加入实施例1步骤9所得化合物9(513mg,1.88mmol),化合物39(949mg,2.25mmol),Cu(301mg,4.70mmol),CuO(376mg,4.70mmol),DMAP(688mg,5.64mmol),氩气保护下加入CH3CN(20mL)后加热至回流,反应12h后停止反应,冷却,加硅藻土过滤,浓缩,柱层析PE∶EA=5∶1(Rf=0.32,PE∶EA=5∶1)得793mg化合物40,收率69%。In the 50mL two-neck bottle reflux device, add compound 9 (513mg, 1.88mmol) obtained in step 9 of Example 1, compound 39 (949mg, 2.25mmol), Cu (301mg, 4.70mmol), CuO (376mg, 4.70mmol), DMAP ( 688mg, 5.64mmol), added CH3 CN (20mL) under the protection of argon, heated to reflux, stopped the reaction after 12h of reaction, cooled, added diatomaceous earth to filter, concentrated, column chromatography PE: EA = 5: 1 (Rf =0.32, PE:EA=5:1) to obtain 793mg of compound 40, yield 69%.
1H-NMR(CDCl3,400MHz):δ10.23(s,1H,CHO),7.74(d,J=8.7Hz,1H,Ar-H),7.50-7.47(m,2H,Ar-H),7.31-7.16(m,7H,Ar-H),7.00-6.97(m,2H,Ar-H),6.53(d,J=8.7Hz,1H,Ar-H),5.08(s,2H,CH2),4.77(d,J=12Hz,1H,CH2),4.71-4.70(m,1H,CH),4.51(d,J=12Hz,1H,CH2),4.00(s,3H,OCH3),3.96(s,3H,OCH3),3.86(s,3H,OCH3),3.84-3.78(m,1H,CH2),3.52-3.47(m,1H,CH2),1.64-1.42(m,6H).13C-NMR(CDCl3,100MHz):δ187.8,165.3,161.7,161.3,159.3,150.5,139.6,139.4,136.3,132.9,132.8,131.1,128.3(2C),128.1(2C),127.7,126.8(2C),123.1,120.3,117.9,114.2(2C),112.6,110.4,98.5,70.6,64.8,64.4,61.8,55.3,52.7,30.2,25.3,19.1.MS(ESI):635.1(M+Na)+.HRMS(ESI):Calcd.for C36H37O9+(M+H)+:613.2438,found:613.2395.1 H-NMR (CDCl3 , 400MHz): δ10.23 (s, 1H, CHO), 7.74 (d, J=8.7Hz, 1H, Ar-H), 7.50-7.47 (m, 2H, Ar-H) , 7.31-7.16(m, 7H, Ar-H), 7.00-6.97(m, 2H, Ar-H), 6.53(d, J=8.7Hz, 1H, Ar-H), 5.08(s, 2H, CH2 ), 4.77(d, J=12Hz, 1H, CH2 ), 4.71-4.70(m, 1H, CH), 4.51(d, J=12Hz, 1H, CH2 ), 4.00(s, 3H, OCH3 ), 3.96 (s, 3H, OCH3 ), 3.86 (s, 3H, OCH3 ), 3.84-3.78 (m, 1H, CH2 ), 3.52-3.47 (m, 1H, CH2 ), 1.64-1.42 ( m, 6H).13 C-NMR (CDCl3 , 100MHz): δ187.8, 165.3, 161.7, 161.3, 159.3, 150.5, 139.6, 139.4, 136.3, 132.9, 132.8, 131.1, 128.3(2C), 128.1(2C ), 127.7, 126.8(2C), 123.1, 120.3, 117.9, 114.2(2C), 112.6, 110.4, 98.5, 70.6, 64.8, 64.4, 61.8, 55.3, 52.7, 30.2, 25.3, 19.1. MS(ESI): 635.1 (M+Na)+ .HRMS(ESI): Calcd. for C36 H37 O9+ (M+H)+ : 613.2438, found: 613.2395.
5.步骤55. Step 5
100mL的单口瓶中加入化合物40(993mg,1.62mmol),对甲苯磺酸(2mg),后加入异丙醇(8mL)和H2O(2mL),加热回流过夜,停止反应,冷却,加入H2O(10mL),乙酸乙酯萃取(3x30mL),有机相水洗,饱和食盐水洗,无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=3∶1(Rf=0.14,PE∶EA=3∶1)得813mg化合物41,收率95%。Add compound 40 (993mg, 1.62mmol), p-toluenesulfonic acid (2mg) into a 100mL single-necked bottle, then add isopropanol (8mL) and H2 O (2mL), heat and reflux overnight, stop the reaction, cool, add H2 O (10 mL), extracted with ethyl acetate (3x30 mL), washed the organic phase with water, washed with saturated brine, dried over anhydrous Na2 SO4 , filtered, concentrated, column chromatography PE:EA=3:1 (Rf =0.14, PE:EA=3:1) to obtain 813mg of compound 41, the yield was 95%.
1H-NMR(CDCl3,400MHz):δ10.23(s,1H,CHO),7.77(d,J=9.1Hz,1H,Ar-H),7.49-7.46(m,2H,Ar-H),7.29-7.16(m,7H,Ar-H),6.99-6.96(m,2H,Ar-H),6.53(d,J=9.1Hz,1H,Ar-H),5.09(s,2H,CH2),4.65(d,J=5.6Hz,2H,CH2),4.01(s,3H,OCH3),3.97(s,3H,OCH3),3.86(s,3H,OCH3),2.74(t,J=6.5Hz,1H,OH).13C-NMR(CDCl3,100MHz):δ187.7,165.5,161.9,160.8,159.4,150.7,139.7,139.2,136.2,135.2,132.7,131.6,128.4(2C),128.1(2C),127.9,126.9(2C),123.5,119.8,117.5,114.2(2C),112.5,110.1,70.7,64.8,61.0,55.3,52.9.MS(ESI):528.7(M+H)+.HRMS(APCI):Calcd.for C31H29O8+(M+H)+:529.1862,found:529.1850.1 H-NMR (CDCl3 , 400MHz): δ10.23 (s, 1H, CHO), 7.77 (d, J=9.1Hz, 1H, Ar-H), 7.49-7.46 (m, 2H, Ar-H) , 7.29-7.16(m, 7H, Ar-H), 6.99-6.96(m, 2H, Ar-H), 6.53(d, J=9.1Hz, 1H, Ar-H), 5.09(s, 2H, CH2 ), 4.65 (d, J=5.6Hz, 2H, CH2 ), 4.01 (s, 3H, OCH3 ), 3.97 (s, 3H, OCH3 ), 3.86 (s, 3H, OCH3 ), 2.74 ( t, J=6.5Hz, 1H, OH).13 C-NMR (CDCl3 , 100MHz): δ187.7, 165.5, 161.9, 160.8, 159.4, 150.7, 139.7, 139.2, 136.2, 135.2, 132.7, 131.6, 128.4 (2C), 128.1(2C), 127.9, 126.9(2C), 123.5, 119.8, 117.5, 114.2(2C), 112.5, 110.1, 70.7, 64.8, 61.0, 55.3, 52.9. MS(ESI): 528.7(M+ H)+ .HRMS(APCI): Calcd.for C31 H29 O8+ (M+H)+ : 529.1862, found: 529.1850.
6.步骤66. Step 6
100mL单口瓶中加入化合物41(797mg,1.51mmol),用MeOH溶解(9mL),加入对甲苯磺酸(74mg,0.39mmol),室温搅拌1h后,加入NaOH(846mg,15.1mmol),加热至回流,反应过夜。停止反应,冷却,减压浓缩除去MeOH,用3N盐酸调pH值至3,乙酸乙酯萃取(4x30mL),无水Na2SO4干燥,过滤,浓缩,得778mg化合物42粗品。Add compound 41 (797mg, 1.51mmol) to a 100mL single-necked bottle, dissolve (9mL) with MeOH, add p-toluenesulfonic acid (74mg, 0.39mmol), stir at room temperature for 1h, add NaOH (846mg, 15.1mmol), and heat to reflux , reacted overnight. The reaction was stopped, cooled, concentrated under reduced pressure to remove MeOH, adjusted to pH 3 with 3N hydrochloric acid, extracted with ethyl acetate (4x30 mL), dried over anhydrous Na2 SO4 , filtered, and concentrated to obtain 778 mg of crude compound 42.
MS(ESI):512.7(M-H)-.MS(ESI): 512.7(MH)- .
7.步骤77. Step 7
将化合物42的粗品(778mg,1.51mmol)和三乙胺(1.7mL,12.1mmol)溶于干燥的CH3CN(30mL)中,将上述制得的溶液室温下缓慢滴加到由碘化-2-氯-1-甲基吡啶(1.54g,6.04mmol)溶于干燥的CH3CN(30mL)所配置的溶液中。滴加完毕后,加热回流反应过夜。停止反应,冷却,减压浓缩除去CH3CN,加入H2O(20mL),DCM萃取(3x30mL),无水Na2SO4干燥,过滤,浓缩,柱层析DCM(Rf=0.58,PE∶EA=2∶1)得138mg化合物43,两步合计收率18%。The crude product of compound 42 (778mg, 1.51mmol) and triethylamine (1.7mL, 12.1mmol) were dissolved in dry CH3 CN (30mL), and the solution prepared above was slowly added dropwise at room temperature to the iodide- 2-Chloro-1-picoline (1.54 g, 6.04 mmol) was dissolved in dryCH3CN (30 mL). After the dropwise addition was completed, the reaction was heated to reflux overnight. The reaction was stopped, cooled, concentrated under reduced pressure to remove CH3 CN, added H2 O (20 mL), extracted with DCM (3x30 mL), dried over anhydrous Na2 SO4 , filtered, concentrated, column chromatography DCM (Rf =0.58, PE :EA=2:1) to obtain 138 mg of compound 43, the total yield of the two steps was 18%.
1H-NMR(CDCl3,400MHz):δ10.37(s,1H,CHO),8.02(d,J=8.7Hz,1H,Ar-H),7.54-7.51(m,2H,Ar-H),7.45-7.36(m,5H,Ar-H),7.23(d,J=2.0Hz,1H,Ar-H),7.08(dd,J=8.7,0.8Hz,1H,Ar-H),6.97-6.94(m,2H,Ar-H),6.83(d,J=2.0Hz,1H,Ar-H),5.28(s,2H,CH2),5.23(s,2H,CH2),4.14(s,3H,OCH3),3.85(s,3H,OCH3).13C-NMR(CDCl3,100MHz):δ187.8,166.0,161.2,159.5,157.7,150.8,144.2,138.3,136.4,133.4,132.2,128.7(2C),128.2,128.0(2C),127.8,127.4(2C),127.1,120.6,119.4,118.8,114.4,114.3(2C),71.5,69.1,64.7,55.3.HRMS(APCI):Calcd.forC30H25O7+(M+H)+:497.1600,found:497.1599.1 H-NMR (CDCl3 , 400MHz): δ10.37 (s, 1H, CHO), 8.02 (d, J=8.7Hz, 1H, Ar-H), 7.54-7.51 (m, 2H, Ar-H) , 7.45-7.36 (m, 5H, Ar-H), 7.23 (d, J=2.0Hz, 1H, Ar-H), 7.08 (dd, J=8.7, 0.8Hz, 1H, Ar-H), 6.97- 6.94(m, 2H, Ar-H), 6.83(d, J=2.0Hz, 1H, Ar-H), 5.28(s, 2H, CH2 ), 5.23(s, 2H, CH2 ), 4.14(s , 3H, OCH3 ), 3.85 (s, 3H, OCH3 ).13 C-NMR (CDCl3 , 100MHz): δ187.8, 166.0, 161.2, 159.5, 157.7, 150.8, 144.2, 138.3, 136.4, 133.4, 132.2, 128.7(2C), 128.2, 128.0(2C), 127.8, 127.4(2C), 127.1, 120.6, 119.4, 118.8, 114.4, 114.3(2C), 71.5, 69.1, 64.7, 55.3.HRMS(APCI): Calcd .for C30 H25 O7+ (M+H)+ : 497.1600, found: 497.1599.
8.步骤88. Step 8
50mL单口瓶中加入化合物43(136mg,0.27mmol),氩气保护下,加入干燥的THF(10mL),冰浴下滴加新戊基溴化镁(0.61mL,1.6mmol),后自然升温至室温搅拌1h,加入饱和NH4Cl淬灭反应,乙酸乙酯萃取(3x30mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=5∶1(Rf=0.30,PE∶EA=3∶1)得119mg化合物44,收率77%。Compound 43 (136mg, 0.27mmol) was added to a 50mL single-necked bottle, under the protection of argon, dry THF (10mL) was added, and neopentylmagnesium bromide (0.61mL, 1.6mmol) was added dropwise under ice-cooling, and then the temperature was naturally raised to Stir at room temperature for 1 h, add saturated NH4 Cl to quench the reaction, extract with ethyl acetate (3x30 mL), dry over anhydrous Na2 SO4 , filter, concentrate, column chromatography PE:EA=5:1 (Rf =0.30, PE :EA=3:1) to obtain 119mg of compound 44, yield 77%.
1H-NMR(CDCl3,400MHz):δ7.60(d,J=8.6Hz,1H,Ar-H),7.54-7.51(m,2H,Ar-H),7.43-7.34(m,5H,Ar-H),7.19(d,J=1.6Hz,1H,Ar-H),6.99(d,J=8.6Hz,1H,Ar-H),6.95-6.92(m,2H,Ar-H),6.80(d,J=1.6Hz,1H,Ar-H),5.27(s,2H,CH2),5.19-5.18(s,3H),3.99(s,3H,OCH3),3.83(s,3H,OCH3),1.93(br s,1H,OH),1.70-1.55(m,2H,CH2),1.03(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ167.3,159.3,154.0,152.0,150.6,145.2,137.6,137.5,136.6,132.3,131.0,128.6(2C),128.0,127.9(2C),127.8,127.3(2C),119.5,119.3,118.0,114.4,114.2(2C),71.5 69.2,66.4,62.6,55.3,52.2,30.7,30.0(3C).MS(ESI):568.7(M+H)+.HRMS(APCI):Calcd.forC35H37O7+(M+H)+:569.2539,found:569.2534.1 H-NMR (CDCl3 , 400MHz): δ7.60 (d, J=8.6Hz, 1H, Ar-H), 7.54-7.51 (m, 2H, Ar-H), 7.43-7.34 (m, 5H, Ar-H), 7.19(d, J=1.6Hz, 1H, Ar-H), 6.99(d, J=8.6Hz, 1H, Ar-H), 6.95-6.92(m, 2H, Ar-H), 6.80(d, J=1.6Hz, 1H, Ar-H), 5.27(s, 2H, CH2 ), 5.19-5.18(s, 3H), 3.99(s, 3H, OCH3 ), 3.83(s, 3H , OCH3 ), 1.93 (br s, 1H, OH), 1.70-1.55 (m, 2H, CH2 ), 1.03 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz) : δ167.3, 159.3, 154.0, 152.0, 150.6, 145.2, 137.6, 137.5, 136.6, 132.3, 131.0, 128.6(2C), 128.0, 127.9(2C), 127.8, 127.3(2C), 119.5, 119.3, 118. 114.4, 114.2 (2C), 71.5 69.2, 66.4, 62.6, 55.3, 52.2, 30.7, 30.0 (3C). MS (ESI): 568.7 (M+H)+ . HRMS (APCI): Calcd. for C35 H37 O7+ (M+H)+ : 569.2539, found: 569.2534.
9.步骤99. Step 9
50mL单口瓶中加入化合物44(108mg,0.19mmol),DMSO溶解(10mL),后加入IBX(106mg,0.38mmol),室温搅拌过夜,停止反应,加入H2O(10mL),DCM萃取(4x20mL),有机相水洗(1x50mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=5∶1(Rf=0.53,PE∶EA=3∶1)得104mg化合物45,收率96%。Compound 44 (108mg, 0.19mmol) was added to a 50mL single-necked bottle, dissolved in DMSO (10mL), then IBX (106mg, 0.38mmol) was added, stirred at room temperature overnight, the reaction was stopped, H2 O (10mL) was added, DCM extraction (4x20mL) , the organic phase was washed with water (1x50mL), dried over anhydrous Na2 SO4 , filtered, concentrated, column chromatography PE: EA = 5: 1 (Rf = 0.53, PE: EA = 3: 1) to obtain 104mg of compound 45, yield The rate is 96%.
1H-NMR(CDCl3,400MHz):δ7.61(d,J=8.6Hz,1H,Ar-H),7.53-7.51(m,2H,Ar-H),7.44-7.36(m,5H,Ar-H),7.21(d,J=1.6Hz,1H,Ar-H),7.03(d,J=8.2Hz,1H,Ar-H),6.96-6.93(m,2H,Ar-H),6.82(d,J=1.6Hz,1H,Ar-H),5.27(s,2H,CH2),5.20(s,2H,CH2),3.96(s,3H,OCH3),3.84(s,3H,OCH3),2.91(s,2H,CH2),1.01(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ202.1,166.3,159.5,156.6,155.0,150.8,144.7,138.1,136.5,133.8,133.7,132.3,128.7(2C),128.2,128.0(2C),127.8,127.4(2C),120.8,119.6,118.5,114.6,114.3(2C),71.6,69.1,63.9,55.4,54.8,31.6,29.9(3C).HRMS(APCI):Calcd.for C35H35O7+(M+H)+:567.2383,found:567.2350.1 H-NMR (CDCl3 , 400MHz): δ7.61 (d, J=8.6Hz, 1H, Ar-H), 7.53-7.51 (m, 2H, Ar-H), 7.44-7.36 (m, 5H, Ar-H), 7.21(d, J=1.6Hz, 1H, Ar-H), 7.03(d, J=8.2Hz, 1H, Ar-H), 6.96-6.93(m, 2H, Ar-H), 6.82(d, J=1.6Hz, 1H, Ar-H), 5.27(s, 2H, CH2 ), 5.20(s, 2H, CH2 ), 3.96(s, 3H, OCH3 ), 3.84(s, 3H, OCH3 ), 2.91 (s, 2H, CH2 ), 1.01 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ202.1, 166.3, 159.5, 156.6, 155.0, 150.8, 144.7, 138.1, 136.5, 133.8, 133.7, 132.3, 128.7(2C), 128.2, 128.0(2C), 127.8, 127.4(2C), 120.8, 119.6, 118.5, 114.6, 114.3, 6C, 7 69.1, 63.9, 55.4, 54.8, 31.6, 29.9 (3C). HRMS (APCI): Calcd. for C35 H35 O7+ (M+H)+ : 567.2383, found: 567.2350.
10.步骤1010. Step 10
氩气保护下,在50mL单口瓶中加入(R)-Me-CBS(51μL,0.051mmol),减压除去其中的甲苯,再加入THF(2.5mL)。降温至-20℃,加入BH3·THF(0.22mL,0.22mmol,1M in THF),后缓慢滴加化合物45(94mg,0.17mmol)的THF溶液(2.5mL),3h滴加完毕。-20℃反应4h后停止反应,加入H2O(3mL)淬灭反应,乙酸乙酯萃取(3x15mL),有机相水洗,无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=5∶1得72mg化合物46,收率74%。Under the protection of argon, (R)-Me-CBS (51 μL, 0.051 mmol) was added to a 50 mL single-necked flask, the toluene was removed under reduced pressure, and then THF (2.5 mL) was added. Cool down to -20°C, add BH3 ·THF (0.22mL, 0.22mmol, 1M in THF), and then slowly add compound 45 (94mg, 0.17mmol) in THF solution (2.5mL) dropwise for 3h. Stop the reaction after reacting at -20°C for 4h, add H2 O (3mL) to quench the reaction, extract with ethyl acetate (3x15mL), wash the organic phase with water, dry over anhydrous Na2 SO4 , filter, concentrate, column chromatography PE:EA =5:1 72mg of compound 46 was obtained, the yield was 74%.
[α]D20=+19°(C=0.2,CHCl3).[α]D20 =+19° (C=0.2, CHCl3 ).
11.步骤1111. Step 11
50mL单口瓶中加入化合物46(68mg,0.12mmol),用EtOH(3mL)和EA(7mL)的混合溶液溶解后加入钯碳(7mg),通入H2,TLC监测至原料消失,过滤,浓缩,柱层析PE∶EA=2∶1(Rf=0.24,PE∶EA=2∶1)得53mg化合物47,收率93%,ee值74%。(手性柱拆分条件:PC-2柱,UV 214nm,正己烷∶异丙醇=20∶30,0.5mL/min)Add compound 46 (68mg, 0.12mmol) to a 50mL single-necked bottle, dissolve it with a mixed solution of EtOH (3mL) and EA (7mL), add palladium carbon (7mg), feed H2 , monitor by TLC until the raw material disappears, filter, and concentrate , column chromatography PE:EA=2:1 (Rf =0.24, PE:EA=2:1) yielded 53mg of compound 47, yield 93%, ee value 74%. (Chiral column separation conditions: PC-2 column, UV 214nm, n-hexane:isopropanol=20:30, 0.5mL/min)
1H-NMR(CDCl3,400MHz):δ7.55(d,J=8.2Hz,1H,Ar-H),7.42-7.39(m,2H,Ar-H),7.21(d,J=2.0Hz,1H,Ar-H),6.95-6.92(m,2H,Ar-H),6.87(d,J=8.2Hz,1H,Ar-H),6.81(br s,1H,OH),6.71(d,J=2.0Hz,1H,Ar-H),5.17-5.14(m,3H),3.98(s,3H,OCH3),3.83(s,3H,OCH3),2.24(br s,1H,OH),1.66-1.52(m,2H,CH2),1.02(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ167.8,159.3,153.8,151.0,147.9,142.4,138.1,137.9,132.1,131.0,127.9(2C),126.2,119.2,118.5,117.6,115.4,114.2(2C),69.3,66.4,62.4,55.3,52.3,30.7,30.1(3C).MS(ESI):478.9(M+H)+.HRMS(APCI):Calcd.for C28H31O7+(M+H)+:479.2070,found:479.2066,[α]D20=+55°(C=0.2,CHCl3).1 H-NMR (CDCl3 , 400MHz): δ7.55 (d, J=8.2Hz, 1H, Ar-H), 7.42-7.39 (m, 2H, Ar-H), 7.21 (d, J=2.0Hz , 1H, Ar-H), 6.95-6.92(m, 2H, Ar-H), 6.87(d, J=8.2Hz, 1H, Ar-H), 6.81(br s, 1H, OH), 6.71(d , J=2.0Hz, 1H, Ar-H), 5.17-5.14 (m, 3H), 3.98 (s, 3H, OCH3 ), 3.83 (s, 3H, OCH3 ), 2.24 (br s, 1H, OH ), 1.66-1.52 (m, 2H, CH2 ), 1.02 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ167.8, 159.3, 153.8, 151.0, 147.9, MS(ESI) ): 478.9 (M+H)+ .HRMS (APCI): Calcd.for C28 H31 O7+ (M+H)+ : 479.2070, found: 479.2066, [α]D20 =+55 ° (C = 0.2, CHCl3 ).
12.步骤1212. Step 12
25mL单口瓶中加入化合物47(7mg,0.015mmol)和干燥的THF(2mL),后加入NaH(0.7mg,0.017mmol),室温搅拌1h,后缓慢滴加对三氟甲基苯甲酰氯(3μL,0.017mmol)的THF(2mL)溶液,过夜后停止反应,直接板层析PE∶EA=3∶1(Rf=0.24,PE∶EA=3∶1)得9mg化合物48,收率90%。Add compound 47 (7mg, 0.015mmol) and dry THF (2mL) into a 25mL single-necked bottle, then add NaH (0.7mg, 0.017mmol), stir at room temperature for 1h, then slowly add p-trifluoromethylbenzoyl chloride (3μL , 0.017mmol) in THF (2mL), the reaction was stopped overnight, and direct plate chromatography PE:EA=3:1 (Rf =0.24, PE:EA=3:1) gave 9mg of compound 48, yield 90% .
1H-NMR(CDCl3,400MHz):δ8.42-8.39(m,2H,Ar-H),7.83-7.80(m,2H,Ar-H),7.61(d,J=8.6Hz,1H,Ar-H),7.47-7.44(m,3H,Ar-H),7.18(d,J=2.0Hz,1H,Ar-H),7.00(d,J=8.6Hz,1H,Ar-H),6.98-6.95(m,2H,Ar-H),5.22(s,2H,CH2),5.17-5.15(m,1H,CH),3.97(s,3H,OCH3),3.85(s,3H,OCH3),1.86(br s,1H,OH),1.68-1.53(m,2H,CH2),1.02(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ166.9,164.1,159.6,154.0,151.0,146.6,142.3,138.4,137.6,135.5,135.1,132.1,131.2,131.1,130.7,128.0,127.8,125.8,125.7,122.3,119.4,118.2,114.3,69.1,66.4,62.9,55.3,52.2,30.7,30.0(3C).19F-NMR(CDCl3,376MHz):δ-63.6.HRMS(APCI):Calcd.for C36H32F3O8-(M-H)-:649.2050,found:649.2085,[α]D20=+4.9°(C=1.0,CHCl3).1 H-NMR (CDCl3 , 400MHz): δ8.42-8.39 (m, 2H, Ar-H), 7.83-7.80 (m, 2H, Ar-H), 7.61 (d, J=8.6Hz, 1H, Ar-H), 7.47-7.44 (m, 3H, Ar-H), 7.18 (d, J=2.0Hz, 1H, Ar-H), 7.00 (d, J=8.6Hz, 1H, Ar-H), 6.98-6.95(m, 2H, Ar-H), 5.22(s, 2H, CH2 ), 5.17-5.15(m, 1H, CH), 3.97(s, 3H, OCH3 ), 3.85(s, 3H, OCH3 ), 1.86 (br s, 1H, OH), 1.68-1.53 (m, 2H, CH2 ), 1.02 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ166.9, 164.1, 159.6, 154.0, 151.0, 146.6, 142.3, 138.4, 137.6, 135.5, 135.1, 132.1, 131.2, 131.1, 130.7, 128.0, 127.8, 125.8, 125.7, 122.3, 169.18.2 66.4, 62.9, 55.3, 52.2, 30.7, 30.0 (3C).19 F-NMR (CDCl3 , 376MHz): δ-63.6. HRMS (APCI): Calcd.for C36 H32 F3 O8- (MH)- : 649.2050, found: 649.2085, [α]D20 =+4.9°(C=1.0, CHCl3 ).
实施例7制备下述化合物,Example 7 prepares the following compounds,
1.步骤11. Step 1
25mL单口瓶中加入实施例6步骤11所得化合物47(22mg,0.046mmol)和干燥的THF(2mL),后加入NaH(2mg,0.051mmol),室温搅拌1h,后缓慢滴加3,5-二(三氟甲基)苯甲酰氯(12μL,0.066mmol)的THF(2mL)溶液,过夜后停止反应,直接板层析PE∶EA=3∶1(Rf=0.67,PE∶EA=2∶1)得10mg化合物49,收率30%。Add compound 47 (22mg, 0.046mmol) obtained in step 11 of Example 6 and dry THF (2mL) into a 25mL one-mouth bottle, then add NaH (2mg, 0.051mmol), stir at room temperature for 1h, and then slowly add 3,5-di (Trifluoromethyl)benzoyl chloride (12μL, 0.066mmol) in THF (2mL) solution, stop the reaction after overnight, direct plate chromatography PE:EA=3:1 (Rf =0.67, PE:EA=2: 1) 10 mg of compound 49 was obtained, with a yield of 30%.
1H-NMR(CDCl3,400MHz):δ8.73(s,2H,Ar-H),8.18(s,1H,Ar-H),7.64(d,J=8.6Hz,1H,Ar-H),7.47-7.45(m,3H,Ar-H),7.21(s,1H,Ar-H),7.01-6.95(m,3H,Ar-H),5.22(s,2H,CH2),5.18-5.15(m,1H,CH),3.98(s,3H,OCH3),3.85(s,3H,OCH3),1.86(br s,1H,OH),1.69-1.54(m,2H,CH2),1.02(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ166.8,162.7,159.6,154.1,150.8,146.5,141.9,138.6,137.7,135.5,132.8,132.4,131.2,131.04,131.00,130.4,128.0,127.9,126.1,124.0,122.1,120.8,119.7,118.1,114.4,69.1,66.4,63.0,55.3,52.2,30.7,30.0(3C).19F-NMR(CDCl3,376MHz):δ-63.3.HRMS(APCI):Calcd.for C37H31F6O8-(M-H)-:717.1923,found:717.1916,[α]D20=+7.0°(C=1.0,CHCl3).1 H-NMR (CDCl3 , 400MHz): δ8.73 (s, 2H, Ar-H), 8.18 (s, 1H, Ar-H), 7.64 (d, J=8.6Hz, 1H, Ar-H) , 7.47-7.45(m, 3H, Ar-H), 7.21(s, 1H, Ar-H), 7.01-6.95(m, 3H, Ar-H), 5.22(s, 2H, CH2 ), 5.18- 5.15 (m, 1H, CH), 3.98 (s, 3H, OCH3 ), 3.85 (s, 3H, OCH3 ), 1.86 (br s, 1H, OH), 1.69-1.54 (m, 2H, CH2 ) , 1.02 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ166.8, 162.7, 159.6, 154.1, 150.8, 146.5, 141.9, 138.6, 137.7, 135.5, 132.8, 132.419 F-NMR3 , 376MHz): δ-63.3.HRMS (APCI): Calcd.for C37 H31 F6 O8- (MH)- : 717.1923, found: 717.1916, [α]D20 =+7.0° (C = 1.0 , CHCl3 ).
实施例8:制备下述化合物,Example 8: Preparation of the following compounds,
1.步骤11. Step 1
25mL单口瓶中加入实施例6步骤11所得化合物47(19mg,0.040mmol)和干燥的THF(2mL),后加入NaH(1.8mg,0.044mmol),室温搅拌1h,后缓慢滴加实施例1步骤18中酰氯b(9mg,0.052mmol)的THF(2mL)溶液,过夜后停止反应,直接板层析PE∶EA=3∶1(Rf=0.37 PE∶EA=3∶1)得18mg化合物50,收率72%。Add compound 47 (19 mg, 0.040 mmol) obtained in Step 11 of Example 6 and dry THF (2 mL) into a 25 mL single-mouth bottle, then add NaH (1.8 mg, 0.044 mmol), stir at room temperature for 1 h, and then slowly add step 1 in Example 1 Acid chloride b (9mg, 0.052mmol) in THF (2mL) solution in 18, the reaction was stopped after overnight, direct plate chromatography PE:EA=3:1 (Rf =0.37 PE:EA=3:1) gave 18mg of compound 50 , yield 72%.
1H-NMR(CDCl3,400MHz):δ7.63(d,J=8.6Hz,1H,Ar-H),7.43-7.40(m,2H,Ar-H),7.20(s,1H,Ar-H),7.08(s,1H,Ar-H),7.04(d,J=8.6Hz,1H,Ar-H),6.95-6.93(m,2H,Ar-H),5.19-5.16(m,3H),3.99(s,3H,OCH3),3.83(s,3H,OCH3),2.35(s,2H),2.00-1.85(m,5H),1.71-1.56(m,2H,CH2),1.48(s,3H,CH3),1.35-1.33(m,4H),1.03(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ191.0,175.3,167.1,159.5,153.9,151.3,147.2,142.4,138.3,137.4,131.4,131.2,128.0,127.6,125.3,122.4,118.4,114.3,69.3,66.4,63.0,58.6,55.3,52.3,42.0,30.7,30.1,29.4,27.8,17.2.HRMS(APCI):Calcd.for C37H41O8-(M-H)-:613.2802,found:613.2816,[α]D20=+16.2°(C=0.5,CHCl3).1 H-NMR (CDCl3 , 400MHz): δ7.63 (d, J=8.6Hz, 1H, Ar-H), 7.43-7.40 (m, 2H, Ar-H), 7.20 (s, 1H, Ar- H), 7.08(s, 1H, Ar-H), 7.04(d, J=8.6Hz, 1H, Ar-H), 6.95-6.93(m, 2H, Ar-H), 5.19-5.16(m, 3H ), 3.99 (s, 3H, OCH3 ), 3.83 (s, 3H, OCH3 ), 2.35 (s, 2H), 2.00-1.85 (m, 5H), 1.71-1.56 (m, 2H, CH2 ), 1.48 (s, 3H, CH3 ), 1.35-1.33 (m, 4H), 1.03 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ191.0, 175.3, 167.1 , 159.5, 153.9, 151.3, 147.2, 142.4, 138.3, 137.4, 131.4, 131.2, 128.0, 127.6, 125.3, 122.4, 118.4, 114.3, 69.3, 66.4, 63.0, 58.6, 55.3, 52.3, 07.3, 9 , 27.8, 17.2. HRMS (APCI): Calcd. for C37 H41 O8- (MH)- : 613.2802, found: 613.2816, [α]D20 = +16.2° (C = 0.5, CHCl3 ).
实施例9:制备下述化合物,Example 9: Preparation of the following compound,
1.步骤11. Step 1
25mL单口瓶中加入实施例1步骤17所得化合物17(30mg,0.081mmol)和干燥的THF(5mL),后加入NaH(3.2mg,0.081mmol)室温搅拌1h,后缓慢滴加对三氟苯甲酰氯(0.013mL,0.089mmol),1h后停止反应,加入H2O(5mL),EA萃取(3x10mL),有机相无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=3∶1(Rf=0.54,PE∶EA=3∶1)得24mg化合物51,产率55%。Add compound 17 (30mg, 0.081mmol) obtained in step 17 of Example 1 and dry THF (5mL) into a 25mL one-mouth bottle, then add NaH (3.2mg, 0.081mmol) and stir at room temperature for 1h, then slowly add p-trifluorobenzyl Acid chloride (0.013mL, 0.089mmol), stop the reaction after 1h, add H2 O (5mL), extract with EA (3x10mL), dry the organic phase over anhydrous Na2 SO4 , filter, concentrate, column chromatography PE:EA=3 :1 (Rf =0.54, PE:EA=3:1) yielded 24 mg of compound 51, yield 55%.
1H-NMR(CDCl3,400MHz):δ8.39(d,2H,J=8.2Hz,Ar-H),7.81(d,2H,J=8.2Hz,Ar-H),7.60(d,1H,J=8.6Hz,Ar-H),7.30(d,1H,J=8.2Hz,Ar-H),7.16(t,1H,J=7.8Hz,Ar-H),7.04(d,1H,J=7.4Hz,Ar-H),6.96(d,1H,J=8.6Hz,Ar-H),5.17-5.15(m,3H),3.96(s,3H,OCH3),1.86(d,1H,J=4.3Hz,OH),1.67-1.52(m,2H,CH2),1.02(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ162.6,159.8,149.7,146.6,143.7,138.0,134.2,127.8,126.8,126.4,123.5,121.5,120.1,115.2,113.9,108.0,64.6,62.1,58.6,48.0,26.4,25.8.HRMS(ESI):Calcd.for C29H27F3O7Na+(M+Na)+:567.1607,found 567.1593.1 H-NMR (CDCl3 , 400MHz): δ8.39(d, 2H, J=8.2Hz, Ar-H), 7.81(d, 2H, J=8.2Hz, Ar-H), 7.60(d, 1H , J=8.6Hz, Ar-H), 7.30(d, 1H, J=8.2Hz, Ar-H), 7.16(t, 1H, J=7.8Hz, Ar-H), 7.04(d, 1H, J =7.4Hz, Ar-H), 6.96(d, 1H, J=8.6Hz, Ar-H), 5.17-5.15(m, 3H), 3.96(s, 3H, OCH3 ), 1.86(d, 1H, J=4.3Hz, OH), 1.67-1.52 (m, 2H, CH2 ), 1.02 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ162.6, 159.8, 149.7, 146.6,143.7 , 138.0, 134.2, 127.8, 126.8, 126.4, 123.5, 121.5, 120.1, 115.2, 113.9, 108.0, 64.6, 62.1, 58.6, 48.0, 26.4, 25.8. H27 F3 O7 Na+ (M+Na)+ : 567.1607, found 567.1593.
实施例10:制备下述化合物,Example 10: Preparation of the following compound,
1.步骤11. Step 1
25mL单口瓶中加入实施例1步骤17所得化合物17(29mg,0.078mmol)和干燥的THF(5mL),后加入NaH(3.4mg,0.086mmol)室温搅拌1h,后缓慢滴加3,5-二(三氟甲基)苯甲酰氯(0.016mL,0.086mmol),1h后停止反应,加入H2O(5mL),EA萃取(3x10mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=10∶1(Rf=0.71,PE∶EA=3∶1)得31mg化合物52,产率65%。Add compound 17 (29mg, 0.078mmol) obtained in step 17 of Example 1 and dry THF (5mL) into a 25mL one-mouth bottle, then add NaH (3.4mg, 0.086mmol) and stir at room temperature for 1h, then slowly add 3,5-di (Trifluoromethyl)benzoyl chloride (0.016mL, 0.086mmol), stop the reaction after 1h, addH2O (5mL), extract with EA (3x10mL), dryover anhydrousNa2SO4 , filter, concentrate, column Analysis of PE: EA = 10: 1 (Rf = 0.71, PE: EA = 3: 1) yielded 31 mg of compound 52 with a yield of 65%.
1H-NMR(CDCl3,400MHz):δ8.71(s,2H,Ar-H),8.17(s,1H,Ar-H),7.62(d,1H,J=8.6Hz,Ar-H),7.30-7.26(m,1H,Ar-H),7.18(t,1H,J=7.8Hz,Ar-H),7.07(d,1H,J=7.4Hz,Ar-H),6.96(d,1H,J=8.6Hz,Ar-H),5.17-5.16(m,3H),3.97(s,3H,OCH3),1.84(d,1H,J=4.3Hz,OH),1.68-1.53(m,2H,CH2),1.02(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ162.5,158.4,149.7,146.4,143.6,137.5,134.3,128.5,128.1,126.9,126.7,126.1,123.9,123.6,123.0,120.2,120.0,119.8,117.0,115.2,113.8,64.6,62.1,58.7,48.0,26.4,25.8.HRMS(ESI):Calcd.for C30H26F6O7Na+(M+Na)+:635.1480,found 635.1473.1 H-NMR (CDCl3 , 400MHz): δ8.71 (s, 2H, Ar-H), 8.17 (s, 1H, Ar-H), 7.62 (d, 1H, J=8.6Hz, Ar-H) , 7.30-7.26(m, 1H, Ar-H), 7.18(t, 1H, J=7.8Hz, Ar-H), 7.07(d, 1H, J=7.4Hz, Ar-H), 6.96(d, 1H, J=8.6Hz, Ar-H), 5.17-5.16(m, 3H), 3.97(s, 3H, OCH3 ), 1.84(d, 1H, J=4.3Hz, OH), 1.68-1.53(m , 2H, CH2 ), 1.02 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ162.5, 158.4, 149.7, 146.4, 143.6, 137.5, 134.3, 128.5, 128.1 , 126.9, 126.7, 126.1, 123.9, 123.6, 123.0, 120.2, 120.0, 119.8, 117.0, 115.2, 113.8, 64.6, 62.1, 58.7, 48.0, 26.4, 25.8. HRMS (ESI): Calcd.for C30 H26 F6 O7 Na+ (M+Na)+ : 635.1480, found 635.1473.
实施例11:制备下述化合物,Example 11: Preparation of the following compound,
1.步骤11. Step 1
100mL的单口瓶中加入H2O(14mL),HBr(3.5mL),后加入2-氨基-5甲基苯甲酸(1g,6.62mmol)使之溶解。冰盐浴下滴加NaNO2(0.498g,7.22mmol)的水溶液(2mL),搅拌1h,缓慢滴加CuBr(1.35g,9.47mmol)的HBr溶液(5mL)。搅拌至不再生成气泡,油浴加热80℃,反应过夜,第二日早停止反应,冷却,过滤,水洗(Rf=0.33,PE∶EA=2∶1)得1.325g化合物53,产率93%。Add H2 O (14 mL), HBr (3.5 mL) into a 100 mL single-necked bottle, and then add 2-amino-5-methylbenzoic acid (1 g, 6.62 mmol) to dissolve it. An aqueous solution (2 mL) of NaNO2 (0.498 g, 7.22 mmol) was added dropwise in an ice-salt bath, stirred for 1 h, and a HBr solution (5 mL) of CuBr (1.35 g, 9.47 mmol) was slowly added dropwise. Stir until no more bubbles are generated, heat in an oil bath at 80°C, react overnight, stop the reaction early the next day, cool, filter, and wash with water (Rf =0.33, PE:EA=2:1) to obtain 1.325 g of compound 53, the yield 93%.
1H-NMR(CDCl3,300MHz):δ7.81(s,1H,Ar-H),7.57(d,1H,J=8.1Hz,Ar-H),7.20(dd,1H,J=8.1,1.5Hz,Ar-H),2.36(s,3H,CH3).1 H-NMR (CDCl3 , 300MHz): δ7.81 (s, 1H, Ar-H), 7.57 (d, 1H, J=8.1Hz, Ar-H), 7.20 (dd, 1H, J=8.1, 1.5Hz, Ar-H), 2.36(s, 3H,CH3 ).
2.步骤22. Step 2
50mL单口瓶中依次加入化合物53(1.228g,5.99mmol),甲醇(7.04mL)浓硫酸(0.71mL),加热回流7h。停止反应,冷却,加入饱和NaHCO3溶液调pH值至7,EA萃取有机相(3x30mL),水洗(1x30mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=100∶1(Rf=0.89,PE∶EA=2∶1)得1.348g化合物54,产率98%。Compound 53 (1.228g, 5.99mmol), methanol (7.04mL) and concentrated sulfuric acid (0.71mL) were sequentially added into a 50mL single-necked bottle, and heated to reflux for 7h. Stop the reaction, cool, add saturated NaHCO3 solution to adjust the pH to 7, extract the organic phase with EA (3x30mL), wash with water (1x30mL), dry over anhydrous Na2 SO4 , filter, concentrate, column chromatography PE:EA=100: 1 (Rf =0.89, PE:EA=2:1) yielded 1.348 g of compound 54, with a yield of 98%.
1H-NMR(CDCl3,300MHz):δ7.60(s,1H,Ar-H),7.52(d,1H,J=8.1Hz,Ar-H),7.21(d,1H,J=7.8Hz,Ar-H),3.92(s,3H,OCH3),2.33(s,3H,CH3).1 H-NMR (CDCl3 , 300MHz): δ7.60(s, 1H, Ar-H), 7.52(d, 1H, J=8.1Hz, Ar-H), 7.21(d, 1H, J=7.8Hz , Ar-H), 3.92(s, 3H, OCH3 ), 2.33(s, 3H, CH3 ).
3.步骤33. Step 3
50mL单口瓶中依次加入NBS(3.26g,18.3mmoL),AIBN(0.143g,0.873mmol),氩气保护下加入化合物54的CCl4(20mL)溶液,加热回流2h,后冷却补加NBS(1.71g,9.6mmol)和AIBN(0.143g,0.873mmol),加热回流2h。停止反应,冷却,过滤,浓缩。加入浓硫酸(8mL),室温搅拌,TCL跟踪反应至原料消失,倒入冰水(30mL)中,EA萃取有机相(3x30mL),饱和NaHCO3洗(1x30mL),水洗(1x30mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=30∶1(Rf=0.55,PE∶EA=5∶1)得1.131g化合物55,收率53%。Add NBS (3.26g, 18.3mmoL) and AIBN (0.143g, 0.873mmol) to a 50mL single-necked bottle successively, add the CCl4 (20mL) solution of compound 54 under the protection of argon, heat and reflux for 2h, and add NBS (1.71mL) after cooling. g, 9.6mmol) and AIBN (0.143g, 0.873mmol), heated to reflux for 2h. The reaction was stopped, cooled, filtered and concentrated. Add concentrated sulfuric acid (8mL), stir at room temperature, follow the reaction with TCL until the raw material disappears, pour into ice water (30mL), extract the organic phase with EA (3x30mL), wash with saturated NaHCO3 (1x30mL), wash with water (1x30mL), anhydrous NaHCO2 SO4 dried, filtered, concentrated, column chromatography PE: EA = 30: 1 (Rf = 0.55, PE: EA = 5: 1) to obtain 1.131 g of compound 55, yield 53%.
1H-NMR(CDCl3,300MHz):δ10.02(s,1H,CHO),8.29(d,1H,J=1.5Hz,Ar-H),7.87(d,1H,J=8.4Hz,Ar-H),7.83(dd,1H,J=8.4,1.5Hz,Ar-H),3.98(s,3H,OCH3).MS(EI):244,242.1 H-NMR (CDCl3 , 300MHz): δ10.02(s, 1H, CHO), 8.29(d, 1H, J=1.5Hz, Ar-H), 7.87(d, 1H, J=8.4Hz, Ar -H), 7.83 (dd, 1H, J=8.4, 1.5Hz, Ar-H), 3.98 (s, 3H, OCH3 ). MS (EI): 244, 242.
4.步骤44. Step 4
100mL单口瓶中加入实施例1步骤3所得化合物3(1.258g,4.01mmol),化合物55(0.811g,3.34mmol),CuBr(0.239g,1.67mmol),Cs2CO3(2.178g,6.68mmol),后加入NMP(10mL),2,2,6,6-四甲基-3,5-庚二酮(0.069mL,0.334mmol),脱气0.5h,后加热至80℃,反应2h后停止反应,冷却,加入H2O(1x30mL),用3N HCl调pH值至4,EA萃取(3x30mL)有机相,水洗(1x50mL),饱和NH4Cl洗(1x30mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=15∶1(Rf=0.12,PE∶EA=20∶1)得1.14g化合物56,收率72%。Compound 3 (1.258g, 4.01mmol), compound 55 (0.811g, 3.34mmol), CuBr (0.239g, 1.67mmol), Cs2 CO3 (2.178g, 6.68mmol) obtained in Step 3 of Example 1 were added to a 100mL one-mouth bottle ), then added NMP (10mL), 2,2,6,6-tetramethyl-3,5-heptanedione (0.069mL, 0.334mmol), degassed for 0.5h, then heated to 80°C, and reacted for 2h Stop the reaction, cool, add H2 O (1x30mL), adjust the pH to 4 with 3N HCl, extract the organic phase with EA (3x30mL), wash with water (1x50mL), wash with saturated NH4 Cl (1x30mL), anhydrous Na2 SO4 Drying, filtration, concentration, and column chromatography PE:EA=15:1 (Rf =0.12, PE:EA=20:1) yielded 1.14 g of compound 56 with a yield of 72%.
1H-NMR(CDCl3,400MHz):δ9.92(s,1H,CHO),8.40(d,1H,J=1.57Hz,Ar-H),7.84-7.81(m,1H,Ar-H),7.27-7.15(m,5H,Ar-H),7.08-7.06(m,2H,Ar-H),7.01(d,1H,J=7.8Hz,Ar-H),6.77(d,1H,J=9.0Hz,Ar-H),5.01(s,2H,OCH2),4.78(d,1H,J=12Hz,OCH2),4.64(s,1H,OCH),4.53(d,1H,J=12Hz,OCH2),3.94(s,3H,COOCH3),3.76-3.45(m,2H,OCH2),1.61-1.40(m,6H,CH2).13C-NMR(CDCl3,100MHz):δ190.1,165.3,162.7,150.3,140.9,136.3,134.9,133.3,132.9,130.0,128.3,127.7,126.7,126.3,122.1,120.1,115.9,114.2,98.3,70.6,64.3,61.8,52.3,30.2,25.3.MS(ESI):499.4(M+Na)+.HRMS(ESI):Calcd.for C28H28O7Na+(M+Na)+:499.1733,found:499.1711.1 H-NMR (CDCl3 , 400MHz): δ9.92 (s, 1H, CHO), 8.40 (d, 1H, J=1.57Hz, Ar-H), 7.84-7.81 (m, 1H, Ar-H) , 7.27-7.15(m, 5H, Ar-H), 7.08-7.06(m, 2H, Ar-H), 7.01(d, 1H, J=7.8Hz, Ar-H), 6.77(d, 1H, J =9.0Hz, Ar-H), 5.01(s, 2H, OCH2 ), 4.78(d, 1H, J=12Hz, OCH2 ), 4.64(s, 1H, OCH), 4.53(d, 1H, J= 12Hz, OCH2 ), 3.94(s, 3H, COOCH3 ), 3.76-3.45(m, 2H, OCH2 ), 1.61-1.40(m, 6H, CH2 ).13 C-NMR(CDCl3 , 100MHz) : δ190.1, 165.3, 162.7, 150.3, 140.9, 136.3, 134.9, 133.3, 132.9, 130.0, 128.3, 127.7, 126.7, 126.3, 122.1, 120.1, 115.9, 114.2, 98.3, 70.6, 38.3, 2 , 25.3. MS (ESI): 499.4 (M+Na)+ . HRMS (ESI): Calcd. for C28 H28 O7 Na+ (M+Na)+ : 499.1733, found: 499.1711.
5.步骤55. Step 5
100mL的单口瓶中依次加入化合物56(1.12g,2.35mmol),PTSA(3mg),加入异丙醇(10mL)和H2O(2.6mL),加热回流过夜,第二日早停止反应,冷却,加入H2O(10mL),EA萃取(3x30mL),H2O洗(1x30mL),无水MgSO4干燥,过滤,浓缩,柱层析PE∶EA=3∶1(Rf=0.14,PE∶EA=3∶1)得0.871g化合物57,收率95%。Add compound 56 (1.12g, 2.35mmol), PTSA (3mg), isopropanol (10mL) and H2 O (2.6mL) to a 100mL single-necked bottle in turn, heat and reflux overnight, stop the reaction early the next day, and cool , added H2 O (10 mL), extracted with EA (3x30 mL), washed with H2 O (1x30 mL), dried with anhydrous MgSO4 , filtered, concentrated, column chromatography PE:EA=3:1 (Rf =0.14, PE :EA=3:1) to obtain 0.871 g of compound 57, yield 95%.
1H-NMR(CDCl3,300MHz):δ9.92(s,1H,CHO),8.41(s,1H,Ar-H),7.85(d,1H,J=8.7Hz,Ar-H),7.24-7.02(m,8H,Ar-H),6.79(d,1H,J=8.7Hz,Ar-H),5.04(s,2H,OCH2),4.58(s,2H,OCH2),3.96(s,3H,COOCH3),2.09(s,1H,OH).HRMS(ESI):Calcd.for C23H20O6Na+(M+Na)+:415.1158,found:415.1154.1 H-NMR (CDCl3 , 300MHz): δ9.92 (s, 1H, CHO), 8.41 (s, 1H, Ar-H), 7.85 (d, 1H, J=8.7Hz, Ar-H), 7.24 -7.02 (m, 8H, Ar-H), 6.79 (d, 1H, J=8.7Hz, Ar-H), 5.04 (s, 2H, OCH2 ), 4.58 (s, 2H, OCH2 ), 3.96 ( s, 3H, COOCH3 ), 2.09 (s, 1H, OH). HRMS (ESI): Calcd. for C23 H20 O6 Na+ (M+Na)+ : 415.1158, found: 415.1154.
6.步骤66. Step 6
100mL的单口瓶中加入化合物57(0.871g,2.22mmol),用MeOH溶解(13mL),加入PTSA(0.19g 1.11mmol),室温搅拌1h,加入NaOH(0.977g,24.42mmol),加热回流,反应过夜。第二日早停止反应,冷却,旋转蒸发出MeOH,用3N HCl调pH值至4,EA萃取(4x30mL),无水Na2SO4干燥,过滤,浓缩,得化合物58粗品0.775g。Add compound 57 (0.871g, 2.22mmol) to a 100mL single-necked bottle, dissolve (13mL) with MeOH, add PTSA (0.19g 1.11mmol), stir at room temperature for 1h, add NaOH (0.977g, 24.42mmol), heat to reflux, and react overnight. The next day, the reaction was stopped, cooled, and MeOH was rotovapped, adjusted to pH 4 with 3N HCl, extracted with EA (4x30mL), dried over anhydrous Na2 SO4 , filtered, and concentrated to obtain 0.775 g of crude compound 58.
1H-NMR(DMSO-d6,300MHz):δ13.21(s,1H,COOH),9.94(s,1H,CHO),8.35(d,1H,J=1.8Hz,Ar-H),7.95-7.91(m,1H,Ar-H),7.33-6.99(m,8H,Ar-H),6.71(d,1H,J=8.4Hz,Ar-H),5.08(s,2H,OCH2),4.47(s,2H,OCH2).MS(ESI):377.1(M-H)-.1 H-NMR (DMSO-d6 , 300MHz): δ13.21 (s, 1H, COOH), 9.94 (s, 1H, CHO), 8.35 (d, 1H, J=1.8Hz, Ar-H), 7.95 -7.91(m, 1H, Ar-H), 7.33-6.99(m, 8H, Ar-H), 6.71(d, 1H, J=8.4Hz, Ar-H), 5.08(s, 2H, OCH2 ) , 4.47(s, 2H, OCH2 ). MS(ESI): 377.1(MH)- .
7.步骤77. Step 7
将化合物58的粗品(0.775g,2.65mmol)和三乙胺(2.28mL,16.4mmol)溶于干燥的CH3CN(20mL)中,将上述制得的溶液室温下缓慢滴加到由碘化-2-氯-1-甲基吡啶(2.091g,8.2mmol)溶于干燥的CH3CN(53mL)所配置的溶液中。滴加完毕后,加热回流反应1h。后停止反应,冷却,旋出CH3CN,加H2O(20mL),DCM萃取(3x30mL),无水Na2SO4干燥,过滤,浓缩,柱层析DCM(Rf=0.67,PE∶EA=2∶1)得0.549g化合物59,两步收率合计69%。The crude product of compound 58 (0.775g, 2.65mmol) and triethylamine (2.28mL, 16.4mmol) were dissolved in dry CH3 CN (20mL), and the solution prepared above was slowly added dropwise to -2-Chloro-1-methylpyridine (2.091 g, 8.2 mmol) was dissolved in dryCH3CN (53 mL). After the dropwise addition was completed, the reaction was heated to reflux for 1 h. Stop the reaction after cooling, spin out CH3 CN, add H2 O (20 mL), extract with DCM (3x30 mL), dry over anhydrous Na2 SO4 , filter, concentrate, column chromatography DCM (Rf =0.67, PE: EA=2:1) to obtain 0.549 g of compound 59, the total yield of the two steps was 69%.
1H-NMR(CDCl3,400MHz):δ10.02(s,1H,CHO),8.13(d,1H,J=2Hz,Ar-H),8.07(dd,1H,J=8.2,2Hz,Ar-H),7.52-7.36(m,6H,Ar-H),7.11-7.04(m,2H,Ar-H),6.79(dd,1H,J=7.4,2Hz,Ar-H),5.24(s,2H,OCH2),5.13(s,2H,OCH2).13C-NMR(CDCl3,100MHz):δ189.7,168.6,156.6,150.7,145.1,136.4,134.5,134.3,131.1,128.7,128.2,127.9,127.5,127.3,125.2,124.5,121.2,115.9,71.3,69.2.HRMS(ESI):Calcd.for C22H15O5-(M-H)-:359.0920,found:359.0914.1 H-NMR (CDCl3 , 400MHz): δ10.02(s, 1H, CHO), 8.13(d, 1H, J=2Hz, Ar-H), 8.07(dd, 1H, J=8.2, 2Hz, Ar -H), 7.52-7.36(m, 6H, Ar-H), 7.11-7.04(m, 2H, Ar-H), 6.79(dd, 1H, J=7.4, 2Hz, Ar-H), 5.24(s , 2H, OCH2 ), 5.13 (s, 2H, OCH2 ).13 C-NMR (CDCl3 , 100MHz): δ189.7, 168.6, 156.6, 150.7, 145.1, 136.4, 134.5, 134.3, 131.1, 128.7,128.2 ,127.9,127.5, 127.3, 125.2, 124.5, 121.2, 115.9, 71.3, 69.2.
8.步骤88. Step 8
100mL单口瓶中加入化合物59(0.15g,0.385mmol),氩气保护下,加入干燥的THF(10mL),冰浴下滴加上述制备好的新戊基溴化镁(0.9mL,2.308mmol),后自然升温至室温搅拌1h,加入饱和NH4Cl淬灭反应,EA萃取(3x30mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=3∶1(Rf=0.13,DCM)得0.173g化合物60,收率97%。Add compound 59 (0.15g, 0.385mmol) to a 100mL single-necked bottle, under the protection of argon, add dry THF (10mL), and add the above-prepared neopentylmagnesium bromide (0.9mL, 2.308mmol) dropwise under ice bath , then naturally warmed to room temperature and stirred for 1 h, quenched the reaction by adding saturated NH4 Cl, extracted with EA (3x30 mL), dried over anhydrous Na2 SO4 , filtered, concentrated, column chromatography PE:EA=3:1 (Rf = 0.13, DCM) to obtain 0.173 g of compound 60, yield 97%.
1H-NMR(CDCl3,400MHz):δ7.57-7.49(m,4H,Ar-H),7.43-7.38(m,2H,Ar-H),7.36-7.31(m,1H,Ar-H),7.20(d,1H,J=8.2Hz,Ar-H),7.07-6.97(m,2H,Ar-H),6.67(dd,1H,J=7.4,1.2Hz,Ar-H),5.23(s,2H,OCH2),5.10(s,2H,OCH2),4.90-4.86(m,1H,OCH),1.75-1.54(m,2H,CH2),1.00(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ170.0,151.1,150.6,146.0,145.0,136.7,131.2,128.7,128.1,128.0,127.3,126.3,126.1,124.5,123.4,121.3,116.0,71.5,71.4,69.4,53.2,30.6,30.2.MS(EI):432,414,361,341,324,293,268,203,147,91,65,57,41.HRMS(ESI):Calcd.for C27H27O5-(M-H)-:431.1859,found:431.1858.1 H-NMR (CDCl3 , 400MHz): δ7.57-7.49 (m, 4H, Ar-H), 7.43-7.38 (m, 2H, Ar-H), 7.36-7.31 (m, 1H, Ar-H ), 7.20 (d, 1H, J=8.2Hz, Ar-H), 7.07-6.97 (m, 2H, Ar-H), 6.67 (dd, 1H, J=7.4, 1.2Hz, Ar-H), 5.23 (s, 2H, OCH2 ), 5.10 (s, 2H, OCH2 ), 4.90-4.86 (m, 1H, OCH), 1.75-1.54 (m, 2H, CH2 ), 1.00 (s, 9H, t- Bu-H).13 C-NMR (CDCl3 , 100MHz): δ170.0, 151.1, 150.6, 146.0, 145.0, 136.7, 131.2, 128.7, 128.1, 128.0, 127.3, 126.3, 126.1, 124.5, 123.4, 121.3, 116.0, 71.5, 71.4, 69.4, 53.2, 30.6, 30.2. Calcd.for C27 H27 O5- (MH)- : 431.1859, found: 431.1858.
9.步骤99. Step 9
100mL单口瓶中加入化合物60(0.056g,0.13mmol),DMSO溶解(10mL),后加入IBX(0.073g,0.26mmol),室温搅拌过夜,第二日早停止反应,加入H2O(10mL),DCM萃取(4x20mL),水洗(1x50mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=4∶1(Rf=0.5,PE∶EA=3∶1)得0.157g化合物61,收率91%。Compound 60 (0.056g, 0.13mmol) was added to a 100mL single-necked bottle, dissolved in DMSO (10mL), then IBX (0.073g, 0.26mmol) was added, stirred at room temperature overnight, and the reaction was stopped early the next day, and H2O (10mL), DCM Extracted (4x20mL), washed with water (1x50mL), dried over anhydrous Na2 SO4 , filtered, concentrated, column chromatography PE:EA=4:1 (Rf =0.5, PE:EA=3:1) yielded 0.157g compound 61, yield 91%.
1H-NMR(CDCl3,400MHz):δ8.17(s,1H,Ar-H),8.12(d,1H,J=8.2Hz,Ar-H),7.51-7.28(m,6H,Ar-H),7.10-7.02(m,2H,Ar-H),6.69(d,1H,J=7.0Hz,Ar-H),5.24(s,2H,OCH2),5.11(s,2H,OCH2),2.86(s,2H,COCH2),1.07(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ198.0,169.1,155.3,150.6,145.3,136.6,136.5,133.8,129.3,128.7,128.1,127.9,127.3,126.6,125.0,123.7,121.2,115.8,71.2,69.2,50.1,31.5,29.3.MS(EI):430,359,339,309,268,253,212,147,139,91,65.HRMS(EI):Calcd.for C27H26O5:430.1780,found:430.1776.1 H-NMR (CDCl3 , 400MHz): δ8.17(s, 1H, Ar-H), 8.12(d, 1H, J=8.2Hz, Ar-H), 7.51-7.28(m, 6H, Ar-H) H), 7.10-7.02 (m, 2H, Ar-H), 6.69 (d, 1H, J=7.0Hz, Ar-H), 5.24 (s, 2H, OCH2 ), 5.11 (s, 2H, OCH2 ), 2.86 (s, 2H, COCH2 ), 1.07 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ198.0, 169.1, 155.3, 150.6, 145.3, 136.6, 136.5, 133.8, 129.3, 128.7, 128.1, 127.9, 127.3, 126.6, 125.0, 123.7, 121.2, 115.8, 71.2, 69.2, 50.1, 31.5, 29.3. , 212, 147, 139, 91, 65. HRMS (EI): Calcd. for C27 H26 O5 : 430.1780, found: 430.1776.
10.步骤1010. Step 10
氩气保护下,在25mL单口瓶中加入(R)-Me-CBS(0.11mL,0.112mmol),后加入THF(5mL)。降温至-20℃,加入BH3(0.37mL,0.374mmol,1M in THF),后缓慢滴加化合物61(0.161g,0.374mmol)的THF溶液(7mL),3h滴加完毕。-20℃反应4h后停止反应,加入H2O(5mL)淬灭反应,EA萃取(3x20mL)有机相,水洗(1x20mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=3∶1(Rf=0.13,PE∶EA=5∶1)得0.095g化合物62,收率59%,转化率80%,ee值95.5%。(手性柱拆分条件:Chiralcel AD-H柱,正己烷∶异丙醇=4∶1,0.7mL/min,保留时间:t=23.19,t=30.22)Under the protection of argon, (R)-Me-CBS (0.11 mL, 0.112 mmol) was added to a 25 mL single-necked bottle, followed by THF (5 mL). Cool down to -20°C, add BH3 (0.37mL, 0.374mmol, 1M in THF), and then slowly add compound 61 (0.161g, 0.374mmol) in THF solution (7mL) dropwise, and the dropwise addition was completed within 3h. Stop the reaction after reacting at -20°C for 4h, add H2 O (5mL) to quench the reaction, extract the organic phase with EA (3x20mL), wash with water (1x20mL), dry over anhydrous Na2 SO4 , filter, concentrate, column chromatography PE: EA=3:1 (Rf =0.13, PE:EA=5:1) yielded 0.095 g of compound 62, with a yield of 59%, a conversion of 80%, and an ee value of 95.5%. (Chiral column separation conditions: Chiralcel AD-H column, n-hexane:isopropanol=4:1, 0.7mL/min, retention time: t=23.19, t=30.22)
11.步骤1111. Step 11
100mL单口瓶中加入化合物62(0.095g,0.22mmol),用EtOH(3mL)和EA(7mL)的混合溶液溶解后加入钯碳(10mg),通入H2,TLC监测至原料消失后,过滤,浓缩,得78mg化合物63,收率定量。Add compound 62 (0.095g, 0.22mmol) to a 100mL single-necked bottle, dissolve it with a mixed solution of EtOH (3mL) and EA (7mL), add palladium carbon (10mg), feed H2 , monitor by TLC until the raw material disappears, and filter , concentrated to obtain 78 mg of compound 63, and the yield was quantitative.
1H-NMR(CDCl3,400MHz):δ7.52-7.49(m,2H,Ar-H),7.12-7.09(m,1H,Ar-H),7.07-7.04(m,1H,Ar-H),6.99-6.94(m,1H,Ar-H),6.75(br s,1H,Ar-OH),6.57(dd,1H,J=7.6,1.4Hz,Ar-H),5.06(s,2H,OCH2),4.87(dd,1H,J=8.8,2.9Hz,OCH),1.73-1.50(m,2H,CH2),1.00(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ170.3,150.0,147.7,145.6,143.2,131.2,126.3,126.2,126.1,124.8,122.9,120.2,117.3,71.4,69.3,53.1,30.6,30.1.HRMS(ESI):Calcd.for C20H21O5-(M-H)-:341.1389,found:341.1415.1 H-NMR (CDCl3 , 400MHz): δ7.52-7.49 (m, 2H, Ar-H), 7.12-7.09 (m, 1H, Ar-H), 7.07-7.04 (m, 1H, Ar-H ), 6.99-6.94 (m, 1H, Ar-H), 6.75 (br s, 1H, Ar-OH), 6.57 (dd, 1H, J=7.6, 1.4Hz, Ar-H), 5.06 (s, 2H , OCH2 ), 4.87 (dd, 1H, J=8.8, 2.9Hz, OCH), 1.73-1.50 (m, 2H, CH2 ), 1.00 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ170.3, 150.0, 147.7, 145.6, 143.2, 131.2, 126.3, 126.2, 126.1, 124.8, 122.9, 120.2, 117.3, 71.4, 69.3, 53.1, 30.6, 30.1. HRMS (ESI): Calcd.for C20 H21 O5- (MH)- : 341.1389, found: 341.1415.
12.步骤1212. Step 12
25mL单口瓶中加入化合物63(21mg,0.061mmol)和干燥的THF(5mL),后加入NaH(2mg,0.077mmol)室温搅拌1h,后缓慢滴加对三氟苯甲酰氯(0.01mL,0.068mmol),1h后停止反应,加入H2O(5mL),EA萃取(3x10mL),无水Na2SO4干燥,过滤,浓缩,柱层析PE∶EA=3∶1(Rf=0.76,PE∶EA=3∶1)得19mg化合物64,产率61%。Add compound 63 (21mg, 0.061mmol) and dry THF (5mL) into a 25mL single-necked bottle, then add NaH (2mg, 0.077mmol) and stir at room temperature for 1h, then slowly add p-trifluorobenzoyl chloride (0.01mL, 0.068mmol ), stop the reaction after 1h, add H2 O (5mL), extract with EA (3x10mL), dry over anhydrous Na2 SO4 , filter, concentrate, column chromatography PE:EA=3:1 (Rf =0.76, PE :EA=3:1) to obtain 19mg of compound 64, the yield was 61%.
1H-NMR(CDCl3,400MHz):δ8.40(d,2H,J=7.9Hz,Ar-H),7.81(d,2H,J=7.9Hz,Ar-H),7.54-7.50(m,2H,Ar-H),7.32-7.29(d,1H,J=7.5Hz,Ar-H),7.19-7.15(m,2H,Ar-H),7.06(d,1H,J=7.1Hz,Ar-H),5.15(s,2H,OCH2),4.89-4.86(m,1H,CH),1.78(d,1H,J=3.6Hz,OH),1.73-1.51(m,2H,CH2),1.00(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ165.2,159.9,145.7,143.5,141.3,137.9,127.0,126.5,123.5,121.8,121.5,120.2,120.0,119.0,67.1,64.9,48.9,26.3,25.8.HRMS(ESI):Calcd.for C29H26F3O7-(M-H)-:513.1525,found:513.1547.1 H-NMR (CDCl3 , 400MHz): δ8.40 (d, 2H, J=7.9Hz, Ar-H), 7.81 (d, 2H, J=7.9Hz, Ar-H), 7.54-7.50 (m , 2H, Ar-H), 7.32-7.29(d, 1H, J=7.5Hz, Ar-H), 7.19-7.15(m, 2H, Ar-H), 7.06(d, 1H, J=7.1Hz, Ar-H), 5.15 (s, 2H, OCH2 ), 4.89-4.86 (m, 1H, CH), 1.78 (d, 1H, J=3.6Hz, OH), 1.73-1.51 (m, 2H, CH2 ), 1.00 (s, 9H, t-Bu-H).13 C-NMR (CDCl3 , 100MHz): δ165.2, 159.9, 145.7, 143.5, 141.3, 137.9, 127.0, 126.5, 123.5, 121.8, 121.5, 120.2, 120.0, 119.0, 67.1, 64.9, 48.9, 26.3, 25.8. HRMS (ESI): Calcd. for C29 H26 F3 O7- (MH)- : 513.1525, found: 513.1547.
实施例12:制备下述化合物,Example 12: Preparation of the following compound,
1.步骤11. Step 1
25mL单口瓶中加入化合物63(26mg,0.076mmol)和干燥的THF(5mL),后加入NaH(2.3mg,0.096mmol)室温搅拌1h,后缓慢滴加3,5-二(三氟甲基)苯甲酰氯(0.015mL,0.084mmol),1h后停止反应,加入H2O(5mL),EA萃取(3x10mL),无水Na2SO4干燥,过滤,浓缩,柱层析DCM(Rf=0.22,PE∶EA=3∶1)得16mg化合物65,产率34%,回收原料8mg,转化率52%。Add compound 63 (26mg, 0.076mmol) and dry THF (5mL) into a 25mL single-necked bottle, then add NaH (2.3mg, 0.096mmol) and stir at room temperature for 1h, then slowly add 3,5-bis(trifluoromethyl) Benzoyl chloride (0.015mL, 0.084mmol), stopped the reaction after 1h, added H2 O (5mL), extracted with EA (3x10mL), dried over anhydrous Na2 SO4 , filtered, concentrated, column chromatography DCM (Rf = 0.22, PE: EA = 3: 1) to obtain 16 mg of compound 65 with a yield of 34%, 8 mg of recovered starting material, and a conversion of 52%.
1H-NMR(CDCl3,400MHz):δ8.72(s,2H,Ar-H),8.17(s,1H,Ar-H),7.55-7.52(m,2H,Ar-H),7.31(d,1H,J=7.8Hz,Ar-H),7.21-7.16(m,2H,Ar-H),7.09(d,1H,J=7.4Hz,Ar-H),5.15(s,2H,OCH2),4.89(d,1H,J=8.2Hz,CH),1.78(d,1H,J=3.1Hz,OH),1.77-1.52(m,2H,CH2),1.00(s,9H,t-Bu-H).13C-NMR(CDCl3,100MHz):δ169.4,162.7,149.9,147.7,145.8,141.8,132.8,132.5,131.3,131.1,130.4,128.2,127.9,127.3,126.1,124.4,124.3.124.1,123.2,121.4,71.4,69.2,53.3,30.6,30.1.HRMS(ESI):Calcd.for C29H24F6O6Na+(M+Na)+:605.1375,found:605.1359.1 H-NMR (CDCl3 , 400MHz): δ8.72(s, 2H, Ar-H), 8.17(s, 1H, Ar-H), 7.55-7.52(m, 2H, Ar-H), 7.31( d, 1H, J=7.8Hz, Ar-H), 7.21-7.16(m, 2H, Ar-H), 7.09(d, 1H, J=7.4Hz, Ar-H), 5.15(s, 2H, OCH2 ), 4.89(d, 1H, J=8.2Hz, CH), 1.78(d, 1H, J=3.1Hz, OH), 1.77-1.52(m, 2H, CH2 ), 1.00(s, 9H, t -Bu-H).13 C-NMR (CDCl3 , 100MHz): δ169.4, 162.7, 149.9, 147.7, 145.8, 141.8, 132.8, 132.5, 131.3, 131.1, 130.4, 128.2, 127.9, 127.3, 126.1, 124.4 , 124.3.124.1, 123.2, 121.4, 71.4, 69.2, 53.3, 30.6, 30.1. HRMS (ESI): Calcd. for C29 H24 F6 O6 Na+ (M+Na)+ : 605.1375, found: 605.1359.
实施例13:目标物抑制CETP活性测试Example 13: Test of target substance inhibiting CETP activity
实验方法:experimental method:
1.用DMSO溶解所有待测化合物,浓度约为500μM,1. Dissolve all the compounds to be tested in DMSO at a concentration of about 500 μM,
2.按下表制备反应体系,于37℃孵育4小时,2. Prepare the reaction system according to the table below, incubate at 37°C for 4 hours,
混合物1Mixture 1
表1Table 1
3.加入8μL LDL和0.5μL[3H]LDL,用TSE缓冲溶液补足反应体系至600μL,3. Add 8 μL LDL and 0.5 μL [3 H]LDL, make up the reaction system to 600 μL with TSE buffer solution,
4.37℃孵育16小时,Incubate at 4.37°C for 16 hours,
5.加入34.24μL LDL沉淀剂dextran sulfate/MgCl2,终浓度分别为0.027%和27mM。混匀,静置10分钟,5. Add 34.24 μL LDL precipitant dextran sulfate/MgCl2 , the final concentrations are 0.027% and 27 mM respectively. Mix well, let stand for 10 minutes,
6.1000g/min离心30分钟,取出后静置10分钟,6. Centrifuge at 1000g/min for 30 minutes, take it out and let it stand for 10 minutes.
7.每管吸取300μL上清液进行闪烁计数。7. Take 300 μL of supernatant from each tube for scintillation counting.
实验结果:Experimental results:
a未测得有效抑制率。a No effective inhibition rate was measured.
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110340808.0ACN103087040B (en) | 2011-11-01 | 2011-11-01 | Penicillide derivative, its preparation method and at pharmaceutical usage |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110340808.0ACN103087040B (en) | 2011-11-01 | 2011-11-01 | Penicillide derivative, its preparation method and at pharmaceutical usage |
| Publication Number | Publication Date |
|---|---|
| CN103087040A CN103087040A (en) | 2013-05-08 |
| CN103087040Btrue CN103087040B (en) | 2015-10-28 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110340808.0AExpired - Fee RelatedCN103087040B (en) | 2011-11-01 | 2011-11-01 | Penicillide derivative, its preparation method and at pharmaceutical usage |
| Country | Link |
|---|---|
| CN (1) | CN103087040B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5089487A (en)* | 1989-06-13 | 1992-02-18 | Bayer Aktiengesellschaft | Circulation-active dibenzo[1,5]dioxocin-5-ones |
| CN101298448A (en)* | 2008-06-27 | 2008-11-05 | 扬州慧清医药科技开发有限公司 | Synthetic method of 2-benzyloxy-3-ethyl-4-methyl-5-chloro-6- [ (tetrahydro-2H-pyrrole-2-oxyl) methyl ] phenol |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10250687A1 (en)* | 2002-10-31 | 2004-05-13 | Bayer Ag | 7H-Dibenzo (b, g) (1,5) dioxocin-5-one derivatives and their use |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5089487A (en)* | 1989-06-13 | 1992-02-18 | Bayer Aktiengesellschaft | Circulation-active dibenzo[1,5]dioxocin-5-ones |
| CN101298448A (en)* | 2008-06-27 | 2008-11-05 | 扬州慧清医药科技开发有限公司 | Synthetic method of 2-benzyloxy-3-ethyl-4-methyl-5-chloro-6- [ (tetrahydro-2H-pyrrole-2-oxyl) methyl ] phenol |
| Publication number | Publication date |
|---|---|
| CN103087040A (en) | 2013-05-08 |
| Publication | Publication Date | Title |
|---|---|---|
| CN112955436B (en) | 6-oxo-1, 6-dihydropyridazine derivatives, preparation method and application thereof in medicines | |
| JP5124285B2 (en) | Compositions and methods for treating cell proliferative disorders | |
| TWI617546B (en) | Imidazoline derivative, preparation method thereof and application thereof in medicine | |
| WO2021218939A1 (en) | Fused ring compound and application thereof in medicine | |
| CN116964058A (en) | KRAS G12D inhibitors and their applications in medicine | |
| WO2018006795A1 (en) | Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof | |
| TW201700461A (en) | Piperidine derivatives, preparation method thereof and application thereof in medicine | |
| JP2025516367A (en) | Fluoroquinoxalinone derivatives selectively inhibiting PARP1 | |
| EP3395809A1 (en) | Benzopiperidine derivative, preparation method thereof and medical use thereof | |
| WO2015024448A1 (en) | Benzo piperidine ring and benzo morpholine ring compounds, manufacturing method therefor, and medical applications thereof | |
| WO2021147889A1 (en) | Isoindoline derivative, and pharmaceutical composition and use thereof | |
| CA2690337A1 (en) | Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics | |
| CN115724843A (en) | SOS1 inhibitors, pharmaceutical compositions comprising the same and uses thereof | |
| CN101787069A (en) | Diosgenin piperazine derivatives and preparation method thereof | |
| CN116903588A (en) | Five-membered and six-membered compound, intermediate, preparation method, composition and application | |
| JP2752630B2 (en) | New benzoic acid derivative and method for producing the same | |
| CN103626763B (en) | Phenanthrene and indole (or quinol) lixidine alkaloid derivatives and their preparation and application of anti-plant virus activity | |
| CN103087040B (en) | Penicillide derivative, its preparation method and at pharmaceutical usage | |
| CN114096525B (en) | Biaryl compounds, pharmaceutical compositions containing them, preparation methods and uses thereof | |
| CN103958484B (en) | Oxazolidinone derivatives, their preparation method and their application in medicine | |
| CN114773378A (en) | Synthesis method of diastereoisomer of penem drug intermediate | |
| WO2022171088A1 (en) | Pyrazolo[3,4-d]pyrimidin-3-one derivative | |
| WO2019161781A1 (en) | Receptor antagonist, pharmaceutical composition comprising same, and usage thereof | |
| WO2020148325A1 (en) | Neutral lxr modulators | |
| TW200922553A (en) | Five-membered heterocyclic compound |
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | Granted publication date:20151028 Termination date:20181101 | |
| CF01 | Termination of patent right due to non-payment of annual fee |